TW201001029A - Liquid crystal aligning agent and liquid crystal aligning element - Google Patents

Liquid crystal aligning agent and liquid crystal aligning element Download PDF

Info

Publication number
TW201001029A
TW201001029A TW098107226A TW98107226A TW201001029A TW 201001029 A TW201001029 A TW 201001029A TW 098107226 A TW098107226 A TW 098107226A TW 98107226 A TW98107226 A TW 98107226A TW 201001029 A TW201001029 A TW 201001029A
Authority
TW
Taiwan
Prior art keywords
liquid crystal
crystal alignment
compound
group
polymer
Prior art date
Application number
TW098107226A
Other languages
Chinese (zh)
Other versions
TWI454805B (en
Inventor
Toshiyuki Akiike
Tsubasa Abe
Katsuhiro Uchiyama
Original Assignee
Jsr Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jsr Corp filed Critical Jsr Corp
Publication of TW201001029A publication Critical patent/TW201001029A/en
Application granted granted Critical
Publication of TWI454805B publication Critical patent/TWI454805B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/52Liquid crystal materials characterised by components which are not liquid crystals, e.g. additives with special physical aspect: solvents, solid particles
    • C09K19/54Additives having no specific mesophase characterised by their chemical composition
    • C09K19/56Aligning agents
    • GPHYSICS
    • G02OPTICS
    • G02FOPTICAL DEVICES OR ARRANGEMENTS FOR THE CONTROL OF LIGHT BY MODIFICATION OF THE OPTICAL PROPERTIES OF THE MEDIA OF THE ELEMENTS INVOLVED THEREIN; NON-LINEAR OPTICS; FREQUENCY-CHANGING OF LIGHT; OPTICAL LOGIC ELEMENTS; OPTICAL ANALOGUE/DIGITAL CONVERTERS
    • G02F1/00Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics
    • G02F1/01Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour 
    • G02F1/13Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour  based on liquid crystals, e.g. single liquid crystal display cells
    • G02F1/133Constructional arrangements; Operation of liquid crystal cells; Circuit arrangements
    • G02F1/1333Constructional arrangements; Manufacturing methods
    • G02F1/1337Surface-induced orientation of the liquid crystal molecules, e.g. by alignment layers

Landscapes

  • Physics & Mathematics (AREA)
  • Chemical & Material Sciences (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Nonlinear Science (AREA)
  • General Physics & Mathematics (AREA)
  • Mathematical Physics (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Optics & Photonics (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Organic Chemistry (AREA)
  • Liquid Crystal (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)

Abstract

The present invention provides a liquid crystal aligning agent, even in the case of take ODF method to producing VA type liquid crystal display element, can provides a liquid crystal aligning film which generating no display unevenness and showing high vertical alignment controllability, besides, properties required for a liquid crystal aligning agent, particularly the printability, are good. The above liquid cryastal aligning agent comprising at least one polymer selected from the group consist of a polyamic acid and an imide polymer thereof, wherein the polyamic acid is obtained by reacting a tetracarboxylic dianhydride with a diamine which comprising a specific diamine represented by the formula (A-10) below.

Description

201001029 六、發明說明: 【發明所屬之技術領域】 本發明涉及液晶配向劑和液晶顯示元件°更具體地 說,涉及即使在液晶顯示元件製造的液晶塡充步驟中採用 液晶滴下方式(ODF方式)時’也能夠形成不會出現0DF不 勻的液晶配向膜的液晶配向劑’以及即使進行長時間連續 驅動顯示品質也不會變差的液晶顯示元件。 【先前技術】 目前,作爲液晶顯示元件’已知具有所謂TN型(扭曲 向列)液晶胞的TN型液晶顯示元件’其在設置了透明導電 膜的基板表面上形成由聚醯胺酸、聚醯亞胺等形成的液晶 ' 配向膜,作爲液晶顯示元件用的基板,將兩塊該基板相對 設置,在其間隙內形成具有正介電各向異性的向列型液晶 層,構成夾層結構的胞,液晶分子的長軸從一塊基板向另 一塊基板連續地扭轉90度。並且,還開發了與TN型液晶 顯示元件相比能夠實現高對比度的STN(超扭曲向列)型液 晶顯示元件和視角依賴性小的IPS (面內切換)型液晶顯示 元件、VA(垂直配向)型液晶顯示元件、視角依賴性小的同 時影像畫面高速回應性優良的光學補償彎曲(OCB)型液晶 顯示元件。 ‘ 作爲這些液晶顯示元件中的液晶配向膜的材料,以前 已知聚醯亞胺、聚醯胺和聚酯等,特別是聚醯亞胺,由於 其耐熱性、與液晶的親和性、機械強度等優良,而被用於 很多液晶顯示元件中。 201001029 而近年來,液晶顯示元件的製造步驟已取得很大的進 步。特別是與基板的大型化一起所採用的大型基板運送技 術和液晶滴下方式(ODF)等技術已倍受關注。這種〇DF方 式,是在形成液晶配向膜的基板上滴下必需量的液晶,使 其在真空下與另一塊基板貼合後,將密封液晶的密封劑進 行UV固化,使整個面板都塡充液晶的方法,是與一直以 來實施的真空注入方式相比,能夠大幅縮短液晶塡充步驟 的工程時間的技術。但是,如果在具有聚醯亞胺類液晶配 向膜的VA型液晶顯示元件的製造過程中採用ODF方式, 會出現產生被稱作爲“ODF不勻”的顯示不勻的麻煩。這 種現象被認爲是由於液晶配向膜的垂直配向控制力不夠而 導致的。 爲了解決聚醯亞胺類液晶配向膜的這種問題,給出了 例如採用由以高含有比率含有具有長鏈烷基等疏水性官能 團的二胺的二胺製得的聚醯亞胺的方法(參考專利文獻1和 2)。該技術被認爲是具有提高垂直配向控制力效果的優良 技術,但是出現了損害液晶配向劑的印刷性的情況。 因此,需要不損害液晶配向劑所需的各種必需性能, 特別是印刷性、能夠形成不會產生上述ODF不勻的液晶配 向膜的液晶配向劑,以及顯示品質優良的液晶顯示元件, 特別是即使長時間連續驅動時畫面品質也不會變差的液晶 顯示元件。 專利文獻 【專利文獻1】日本特開平9 - 24 1 646號公報 201001029 【專利文獻2】日本特開200 1 — 3 05 549號公報 【發明內容】 本發明的目的是’提供即使在VA型液晶顯示元件的 製造過程中採用ODF方式時’也能夠形成不會產生顯示不 勻且顯示高垂直配向控制力的液晶配向膜’並且作爲液晶 配向劑所需的各種性能’特別是印刷性優良的液晶配向 劑,以及顯示品質優異的液晶顯示元件。 本發明進一步的其他目的和優點,可以由以下的說明 看出。 根據本發明,本發明的上述目的和優點,第一,由一 種液晶配向劑達成’其包括選自聚醯胺酸及其醯亞胺化聚 合物構成的群組中的至少一種聚合物’該聚醯胺酸使四羧 酸二酐與含有下述式(A)表示的化合物的二胺反應所製得201001029 SUMMARY OF THE INVENTION Technical Field The present invention relates to a liquid crystal alignment agent and a liquid crystal display element. More specifically, it relates to a liquid crystal dropping method (ODF method) even in a liquid crystal charging step in which a liquid crystal display element is manufactured. In the case of 'liquid crystal alignment agent' which does not cause a liquid crystal alignment film of 0DF unevenness, and a liquid crystal display element which does not deteriorate even if the display quality is continuously driven for a long period of time. [Prior Art] At present, as a liquid crystal display element, a TN type liquid crystal display element having a so-called TN type (twisted nematic) liquid crystal cell is known, which is formed of polylysine on a surface of a substrate on which a transparent conductive film is provided. A liquid crystal aligning film formed of yttrium imine or the like is used as a substrate for a liquid crystal display element, and two of the substrates are opposed to each other, and a nematic liquid crystal layer having positive dielectric anisotropy is formed in the gap to form a sandwich structure. The long axis of the liquid crystal molecules is continuously twisted by 90 degrees from one substrate to the other. Furthermore, an STN (Super Twisted Nematic) liquid crystal display element and a IPS (in-plane switching) type liquid crystal display element with high contrast ratio and a VA (vertical alignment) capable of achieving high contrast compared to a TN type liquid crystal display element have been developed. The liquid crystal display element has an optical compensation curved (OCB) type liquid crystal display element which is excellent in viewing angle dependence and excellent in high-speed response of an image. As a material of the liquid crystal alignment film in these liquid crystal display elements, polyiminoimine, polyamide, polyester, and the like, particularly polyimine, have been previously known, because of their heat resistance, affinity with liquid crystal, and mechanical strength. It is excellent and is used in many liquid crystal display elements. 201001029 In recent years, the manufacturing steps of liquid crystal display elements have made great progress. In particular, technologies such as large-scale substrate transport technology and liquid crystal dropping method (ODF) used together with the enlargement of substrates have attracted attention. In the 〇DF method, a necessary amount of liquid crystal is dropped on a substrate on which a liquid crystal alignment film is formed, and after bonding to another substrate under vacuum, the liquid crystal sealing agent is UV-cured to fill the entire panel. The liquid crystal method is a technique capable of greatly shortening the engineering time of the liquid crystal charging step as compared with the conventional vacuum injection method. However, if the ODF method is employed in the production process of a VA type liquid crystal display element having a polyimine-based liquid crystal alignment film, there is a problem that display unevenness called "ODF unevenness" occurs. This phenomenon is considered to be caused by insufficient vertical alignment control force of the liquid crystal alignment film. In order to solve such a problem of the polyimine-based liquid crystal alignment film, a method of using a polyimine prepared by using a diamine containing a diamine having a hydrophobic functional group such as a long-chain alkyl group in a high content ratio is given, for example. (Refer to Patent Documents 1 and 2). This technique is considered to be an excellent technique for improving the effect of the vertical alignment control force, but a case where the printability of the liquid crystal alignment agent is impaired occurs. Therefore, there is a need for a liquid crystal alignment element which does not impair the various required properties required for a liquid crystal alignment agent, particularly a printability, a liquid crystal alignment film which can form a liquid crystal alignment film which does not cause the above ODF unevenness, and a liquid crystal display element which is excellent in display quality, particularly even A liquid crystal display element in which the picture quality does not deteriorate when continuously driven for a long time. [Patent Document 1] Japanese Laid-Open Patent Publication No. Hei. No. Hei. No. Hei. No. Hei. No. Hei. No. Hei. When the ODF method is used in the manufacturing process of the display element, it is also possible to form a liquid crystal alignment film which does not cause display unevenness and exhibit high vertical alignment control force, and various properties required as a liquid crystal alignment agent, in particular, liquid crystal excellent in printability. An alignment agent and a liquid crystal display element excellent in display quality. Further objects and advantages of the present invention will be apparent from the following description. According to the present invention, the above objects and advantages of the present invention, firstly, achieve a 'liquid crystal alignment agent comprising at least one polymer selected from the group consisting of polylysine and its ruthenium iodide polymer' Polylysine is obtained by reacting a tetracarboxylic dianhydride with a diamine containing a compound represented by the following formula (A).

(式(A)中,R1和R111各自獨立地爲醚鍵、硫醚鍵、酯 鍵或硫酯鍵,其中酯鍵和硫酯鍵的方向不限,R11爲亞甲基 或碳原子數爲2〜10的亞烷基,RIV爲單鍵、亞甲基或亞乙 基,X爲具有甾體骨架的碳原子數爲17〜40的1價有機基 團)。 201001029 本發明的上述目的和優點,第二,由具有由上述液晶 配向劑形成的液晶配向膜的液晶顯示元件達成。 【實施方式】 本發明的液晶配向劑包括選自聚醯胺酸及其醯亞胺化 聚合物構成的群組中的至少一種聚合物,該聚醯胺酸使四 羧酸二酐與含有上述式(A)表示的化合物的二胺反應所製 得。 [聚醯胺酸] 本發明液晶配向劑可以包括的聚醯胺酸,可以通過使 四羧酸二酐與含有上述式(A)表示的化合物的二胺反應而 合成。 [四羧酸二酐] 作爲本發明液晶配向劑可以包括的聚醯胺酸的合成中 所用的四羧酸二酐,可以列舉例如丁烷四羧酸二酐、 1,2,3,4-環丁烷四羧酸二酐、1,2-二甲基-1,2,3,4-環丁烷四 羧酸二酐、1,3-二甲基-1,2,3,4-環丁烷四羧酸二酐、1,3-二 氯·1,2,3,4-環丁烷四羧酸二酐、1,2,3,4-四甲基-1,2,3,4-瓌 丁烷四羧酸二酐、1,2,3,4-環戊烷四羧酸二酐' 1,2,4,5-瓌 己烷四羧酸二酐、3,3’,4,4’-二環己基四羧酸二酐、2,3,5-三羧基環戊基醋酸二酐、3,5,6-三羧基降冰片烷-2-醋酸二 酐、2,3,4,5-四氫呋喃四羧酸二酐、l,3,3a,4,5,9b-六氫- 5-(四 氫-2,5-二氧代-3-呋喃基)-萘[1,2-c]-呋喃-1,3-二酮、 1,3,3&,4,5,913-六氫-5-甲基-5-(四氫-2,5-二氧代-3-呋喃基)-萘[l,2-c]-呋喃-1,3-二酮、1,3,3&,4,5,91)-六氫-5-乙基-5-(四 201001029 氫-2,5-二氧代-3-呋喃基)_萘呋喃'3_二酮、 1,3九4,5,91>-六氫-7-甲基.5_(四氫_2,5_二氧代_3_咲喃基)_ 萘[l,2,cl·呋喃-U3-二酮、^^^’^六氫+乙基^四 氫-2,5-—氧代-3-呋喃基卜萘tl,2_c卜呋喃·〗,3·二酮、 l,3,3a,4,5,9b-六氫-8-甲基_5_(四氫_2,5_二氧代_3_呋喃基卜 萘 n,2-C]-咲喃-U3·二酮、1,3,33,4,5,9^六氫_8_乙基_5_(四 氫-2,5 -—氧代-3 -呋喃基)_萘n,2_c卜呋喃-丨丄二酮、 ^^’^外-六氣-^-二甲基^四氧^卜二氧代小咲喃 基)-萘n,2-C]-肤喃-二酮、5·(2,5·二氧代四氫咲喃 基)-3-甲基-3-環己烯_1,2_二羧酸二酐、雙環[2 2二]·辛_7_ 烯-2,3,5’6-四羧酸二酐、3_氧雜雙環[321]辛烷_2,4_二酮 -6-螺-3’-(四氫呋喃-2’,5,.二酮)、5_(2,5_二氧代四氨小咲 喃基)-3-甲基-3-環己烯_1>2-二羧酸酐、3,5,6_三羧基_2_羧 基降冰片烷-2:3,5:6-二酐、4,9_二氧雜三環[5.3.1.〇26]十— 烷-3,5,8,10-四酮、下述式(T_I}和(T_nm示的化合物等 脂肪族四羧酸二酐和脂環式四竣酸二酐; Γ\(In the formula (A), R1 and R111 are each independently an ether bond, a thioether bond, an ester bond or a thioester bond, wherein the direction of the ester bond and the thioester bond is not limited, and R11 is a methylene group or a carbon number is 2 to 10 alkylene groups, RIV is a single bond, methylene or ethylene group, and X is a monovalent organic group having a steroid skeleton of 17 to 40 carbon atoms). 201001029 The above objects and advantages of the present invention are, in a second, achieved by a liquid crystal display element having a liquid crystal alignment film formed of the above liquid crystal alignment agent. [Embodiment] The liquid crystal alignment agent of the present invention comprises at least one polymer selected from the group consisting of polylysine and a quinone imidized polymer thereof, the polyphthalic acid is a tetracarboxylic dianhydride and contains the above The diamine reaction of the compound represented by the formula (A) is carried out. [Polyuric acid] The polyphthalic acid which may be included in the liquid crystal alignment agent of the present invention can be synthesized by reacting a tetracarboxylic dianhydride with a diamine containing the compound represented by the above formula (A). [Tetracarboxylic dianhydride] The tetracarboxylic dianhydride used in the synthesis of the polyamic acid which may be included in the liquid crystal alignment agent of the present invention may, for example, be butane tetracarboxylic dianhydride, 1,2,3,4- Cyclobutane tetracarboxylic dianhydride, 1,2-dimethyl-1,2,3,4-cyclobutanetetracarboxylic dianhydride, 1,3-dimethyl-1,2,3,4- Cyclobutane tetracarboxylic dianhydride, 1,3-dichloro-1,2,3,4-cyclobutanetetracarboxylic dianhydride, 1,2,3,4-tetramethyl-1,2,3 , 4-anthracene tetracarboxylic dianhydride, 1,2,3,4-cyclopentane tetracarboxylic dianhydride 1, 1,2,4,5-nonane hexane tetracarboxylic dianhydride, 3,3' , 4,4'-dicyclohexyltetracarboxylic dianhydride, 2,3,5-tricarboxycyclopentyl acetic acid dianhydride, 3,5,6-tricarboxynorbornane-2-acetic acid dianhydride, 2, 3,4,5-tetrahydrofuran tetracarboxylic dianhydride, 1,3,3a,4,5,9b-hexahydro-5-(tetrahydro-2,5-dioxo-3-furanyl)-naphthalene 1,2-c]-furan-1,3-dione, 1,3,3&,4,5,913-hexahydro-5-methyl-5-(tetrahydro-2,5-dioxo-3 -furyl)-naphthalene [l,2-c]-furan-1,3-dione, 1,3,3&,4,5,91)-hexahydro-5-ethyl-5-(four 201001029 Hydrogen-2,5-dioxo-3-furanyl)-naphthalene furan '3_dione, 1,3,9,4,5,91>-hexahydrogen -7-Methyl.5_(tetrahydro-2,5-dioxo-3-indolyl)_naphthalene [l,2,cl·furan-U3-dione, ^^^'^hexahydro + B ^^tetrahydro-2,5-oxo-3-furanylnaphthalene tl,2_cbufuran·,3·dione, l,3,3a,4,5,9b-hexahydro-8-A _5_(tetrahydro-2,5-dioxo-3-furanylnaphthalene n,2-C]-furan-U3·dione, 1,3,33,4,5,9^hexahydro _8_Ethyl_5_(tetrahydro-2,5-oxo-3-furanyl)-naphthalene n,2_cbufuran-indanedione, ^^'^external-six-gas-^-dimethyl ^^4O^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^ -3-cyclohexene-1,2-dicarboxylic dianhydride, bicyclo[2 2 bis]·oct-7-ene-2,3,5'6-tetracarboxylic dianhydride, 3_oxabicyclo[321 Octane-2,4-dione-6-spiro-3'-(tetrahydrofuran-2',5,.dione), 5-(2,5-dioxotetraammonium)--3- Methyl-3-cyclohexene_1>2-dicarboxylic anhydride, 3,5,6-tricarboxy-2-oxo-norbornane-2:3,5:6-dianhydride, 4,9-diox Heterotricyclo[5.3.1.〇26]dec-alkane-3,5,8,10-tetraketone, the following formula (T_I} and (such as T_nm compounds, aliphatic tetracarboxylic dianhydride and alicyclic) four Citrate dianhydride; Γ\

(T-l \ (Τ-ΙΙ) (上述式中’ R1和R3各自表示具有芳香環的2價有機 基團’ R和R4各自表示氫原子或者烷基,存在的多個R2 201001029 和R4各自可以相同,也可以不同); 均苯四酸二酐、3,3’,4,4’ -二苯酮四羧酸二酐、 3,3’,4,4’-二苯基楓四羧酸二酐、1,4,5,8-萘四羧酸二酐、 2,3,6,7-萘四羧酸二酐、3,3’,4,4’-二苯基醚四羧酸二酐、 3,3’,4,4’-二甲基二苯基矽烷四羧酸二酐、3,3’,4,4’-四苯基 矽烷四羧酸二酐、1,2,3,4 -呋喃四羧酸二酐、4,4’-雙(3,4-二羧基苯氧基)二苯基硫醚二酐、4,4’-雙(3,4-二羧基苯氧基) 二苯基楓二酐、4,4’-雙(3,4-二羧基苯氧基)二苯基丙烷二 酐、3,3’,4,4’ -全氟異亞丙基二鄰苯二甲酸二酐、3,3’,4,4’-聯苯四羧酸二酐、2,2’,3,3’-聯苯四羧酸二酐、雙(鄰苯二甲 酸)苯膦氧化物二酐、對亞苯基-二(三苯基鄰苯二甲酸)二 酐、間亞苯基-雙(三苯基鄰苯二甲酸)二酐、雙(三苯基鄰苯 二甲酸)-4,4二苯醚二酐、雙(三苯基鄰苯二甲酸)-4,4’-二 苯基甲烷二酐、乙二醇-雙(脫水偏苯三酸酯)、丙二醇-雙(脫 水偏苯三酸酯)、1,4-丁二醇-雙(脫水偏苯三酸酯)、1,6-己 二醇-雙(脫水偏苯三酸酯)、1,8-辛二醇-雙(脫水偏苯三酸 酯)、2,2-雙(4-羥苯基)丙烷-雙(脫水偏苯三酸酯)、下述式 (T-1)〜(T-4)各自表示的化合物等芳香族四羧酸二酐。 它們可以一種單獨或兩種以上組合使用。 201001029(Tl \ (Τ-ΙΙ) (In the above formula, 'R1 and R3 each represent a divalent organic group having an aromatic ring' R and R4 each represent a hydrogen atom or an alkyl group, and a plurality of R2 201001029 and R4 present may each be the same , or different); pyromellitic dianhydride, 3,3',4,4'-benzophenonetetracarboxylic dianhydride, 3,3',4,4'-diphenyl maple tetracarboxylic acid Anhydride, 1,4,5,8-naphthalenetetracarboxylic dianhydride, 2,3,6,7-naphthalenetetracarboxylic dianhydride, 3,3',4,4'-diphenyl ether tetracarboxylic acid Anhydride, 3,3',4,4'-dimethyldiphenylnonanetetracarboxylic dianhydride, 3,3',4,4'-tetraphenylnonanetetracarboxylic dianhydride, 1,2,3 , 4-furan tetracarboxylic dianhydride, 4,4'-bis(3,4-dicarboxyphenoxy)diphenyl sulfide dianhydride, 4,4'-bis(3,4-dicarboxyphenoxy Diphenyltriamine, 4,4'-bis(3,4-dicarboxyphenoxy)diphenylpropane dianhydride, 3,3',4,4'-perfluoroisopropylidene Phthalic phthalic anhydride, 3,3',4,4'-biphenyltetracarboxylic dianhydride, 2,2',3,3'-biphenyltetracarboxylic dianhydride, bis(phthalic acid) Phenylphosphine oxide dianhydride, p-phenylene-bis(triphenylphthalic acid) II Anhydride, m-phenylene-bis(triphenylphthalic acid) dianhydride, bis(triphenylphthalic acid)-4,4 diphenyl ether dianhydride, bis(triphenylphthalic acid) -4,4'-diphenylmethane dianhydride, ethylene glycol-bis(hydrogen trimellitate), propylene glycol-bis(hydroper trimellitate), 1,4-butanediol-double (dehydration) Trimellitic acid ester), 1,6-hexanediol-bis(hydroper trimellitate), 1,8-octanediol-bis(anhydrotrimellitic acid ester), 2,2-dual (4 -Hydroxyphenyl)propane-bis(hydrogen trimellitate), an aromatic tetracarboxylic dianhydride such as a compound represented by the following formulas (T-1) to (T-4). They may be one or two The above combination is used. 201001029

ch3 /CH3Ch3 /CH3

本發明液晶配向劑可以包括的聚醯胺酸的合成中所用 的四羧酸二酐,從能夠使其表現良好的液晶配向性的角度 -10- 201001029 出發,上述當中較佳含有選自丁烷四羧酸二酐、1,2,3,4-環 丁烷四羧酸二酐、1,3-二甲基-1,2,3,4-環丁烷四羧酸二酐、 1,2,3,4-環戊烷四羧酸二酐、2,3,5-三羧基環戊基醋酸二 酐、l,3,3a,4,5,9b-六氫-5-(四氫-2,5-二氧代-3-呋喃基)-萘 [1,2-c]-呋喃-1,3-二酮、1,3,3a,4,5,9b-六氫-8-甲基- 5-(四氫 -2,5-二氧代-3-呋喃基)-萘[l,2-c]-呋喃-1,3-二酮、 1,3,3a,4,5,9b-六氫-5,8-二甲基- 5-(四氫- 2,5-二氧代-3-呋喃 基)-萘[l,2-c] -呋喃-1,3-二酮、雙環[2.2.2] -辛-7-烯- 2,3,5,6-四羧酸二酐、3-氧雜雙環[3.2.1]辛烷-2,4-二酮-6-螺-3’-(四 氫呋喃- 2’,5’-二酮)、5-(2,5 -二氧代四氫-3-呋喃基)-3 -甲基 •3-環己烯-1,2-二羧酸酐、3,5,6-三羧基-2-羧基降冰片烷 -2:3,5:6-二酐、4,9-二氧雜三環[5.3.1.02’6]-(——烷-3,5, 8,10-四酮、均苯四酸二酐、3,3’,4,4’-二苯酮四羧酸二酐、 3,3’,4,4’-二苯基碾四羧酸二酐、2,2’,3,3’ -聯苯四羧酸二 酐、1,4,5,8-萘四羧酸二酐、上述式(T— I)表示的化合物中 的下述式(T - 5)〜(T - 7)各自表示的化合物以及上述式(T - II)表示的化合物中的下述式(T_ 8)表示的化合物構成的 群組中選出的至少一種(以下稱爲“特定四羧酸二酐 ⑴’’)。 -11 - 201001029The tetracarboxylic dianhydride used in the synthesis of polyphthalic acid which may be included in the liquid crystal alignment agent of the present invention is derived from the viewpoint of liquid crystal alignment which can be excellent in performance - 201001029, and preferably contains a selected butane. Tetracarboxylic dianhydride, 1,2,3,4-cyclobutanetetracarboxylic dianhydride, 1,3-dimethyl-1,2,3,4-cyclobutanetetracarboxylic dianhydride, 1, 2,3,4-cyclopentanetetracarboxylic dianhydride, 2,3,5-tricarboxycyclopentyl acetic acid dianhydride, 1,3,3a,4,5,9b-hexahydro-5-(tetrahydrogen) -2,5-dioxo-3-furanyl)-naphthalene [1,2-c]-furan-1,3-dione, 1,3,3a,4,5,9b-hexahydro-8- Methyl-5-(tetrahydro-2,5-dioxo-3-furanyl)-naphthalene[l,2-c]-furan-1,3-dione, 1,3,3a,4,5 ,9b-hexahydro-5,8-dimethyl-5-(tetrahydro-2,5-dioxo-3-furanyl)-naphthalene[l,2-c]-furan-1,3-di Ketone, bicyclo[2.2.2]-oct-7-ene-2,3,5,6-tetracarboxylic dianhydride, 3-oxabicyclo[3.2.1]octane-2,4-dione-6 - spiro-3'-(tetrahydrofuran-2',5'-dione), 5-(2,5-dioxotetrahydro-3-furanyl)-3-methyl•3-cyclohexene-1 ,2-dicarboxylic anhydride, 3,5,6-tricarboxy-2-carboxynorbornane-2:3,5:6-dianhydride 4,9-dioxatricyclo[5.3.1.02'6]-(-alkane-3,5,8,10-tetraketone, pyromellitic dianhydride, 3,3',4,4'- Benzophenone tetracarboxylic dianhydride, 3,3',4,4'-diphenyltricarboxylic dianhydride, 2,2',3,3'-biphenyltetracarboxylic dianhydride, 1,4 , 5,8-naphthalenetetracarboxylic dianhydride, a compound represented by the following formula (T - 5) to (T - 7) in the compound represented by the above formula (T-I), and the above formula (T - II) At least one selected from the group consisting of the compounds represented by the following formula (T-8) in the compound to be represented (hereinafter referred to as "specific tetracarboxylic dianhydride (1)''). -11 - 201001029

(Τ-5)(Τ-5)

(Τ-8) 作爲特定四羧酸二酐(1),特佳爲選自1,2,3,4· 四羧酸二酐、2,3,5-三羧基環戊基醋酸二酐、l,3,3a: 六氫-5-(四氫-2,5-二氧代-3-呋喃基)-萘[1,2-(:]-呋 二酮、1,3,3&,4,5,91)-六氫-8-甲基-5-(四氫-2,5-二氧 喃基)-萘[l,2-c]-呋喃-1,3-二酮、3-氧雜雙環[3.2 -2,4-二酮-6-螺-3’-(四氫呋喃-2’,5’-二酮)、5-(2,5-四氫-3-呋喃基)-3 -甲基-3-環己烯-1,2 -二羧酸酐、3 羧基-2-羧基降冰片烷-2:3,5:6-二酐、4,9 -二氧 [5.3.1.02’6]十一烷-3, 5,8 ,10 -四酮、均苯四酸二酐和 (T- 5)表示的化合物構成的群組中的至少一種。 本發明液晶配向劑可以包括的聚醯胺酸的合成 環丁烷 ,4,5,9b-喃-1,3 -代-3-呋 .1]辛烷 •二氧代 丨,5,6 -二 雜三環 上述式 中所使 -12- 201001029 用的四羧酸二酐中,相對於全部四羧酸二酐,較佳含有20 莫耳%以上的上述特定四羧酸二酐(1),更佳含有50莫耳% 以上,特佳含有8 0莫耳%以上。 本發明液晶配向劑中可以含有的聚醯胺酸的合成用二 胺’是含有上述式(A)表示的化合物的二胺》 上述式(A)中的R1和R111較佳各自獨立地爲醚鍵或酯 鍵。該酯鍵的方向不限。作爲R11,較佳碳原子數爲2〜4 的亞烷基。作爲RIV,較佳爲單鍵或亞甲基。 上述式(A)的X中的甾體骨架,是指環戊烷一全氫菲骨 架或其所含的碳-碳鍵中的一個或多個改爲雙鍵的骨架。 作爲具有這種留體骨架的X基團,可以列舉例如下述式(X —1)〜(X- 4)各自表示的基團,(Τ-8) As the specific tetracarboxylic dianhydride (1), it is particularly preferably selected from the group consisting of 1,2,3,4·tetracarboxylic dianhydride and 2,3,5-tricarboxycyclopentyl acetic acid dianhydride. l,3,3a: hexahydro-5-(tetrahydro-2,5-dioxo-3-furanyl)-naphthalene [1,2-(:]-furenedione, 1,3,3& 4,5,91)-hexahydro-8-methyl-5-(tetrahydro-2,5-dioxoyl)-naphthalene [l,2-c]-furan-1,3-dione, 3 -oxabicyclo[3.2 -2,4-dione-6-spiro-3'-(tetrahydrofuran-2',5'-dione), 5-(2,5-tetrahydro-3-furanyl)- 3-methyl-3-cyclohexene-1,2-dicarboxylic anhydride, 3 carboxy-2-carboxynorbornane-2:3,5:6-dianhydride, 4,9-dioxo[5.3.1.02 '6] At least one of the group consisting of undecane-3, 5,8,10-tetraketone, pyromellitic dianhydride, and a compound represented by (T-5). The liquid crystal alignment agent of the present invention may comprise a synthesis of polybutyric acid, cyclobutane, 4,5,9b-furo-1,3-substituted-3-furo.1]octane•dioxo,5,6- In the tetracarboxylic dianhydride used in the above formula, -12-201001029, the tetracarboxylic dianhydride used in the above formula preferably contains 20 mol% or more of the above specific tetracarboxylic dianhydride (1). More preferably, it contains more than 50% by mole, and particularly preferably contains more than 80% by mole. The diamine for synthesizing polyglycine which may be contained in the liquid crystal alignment agent of the present invention is a diamine containing the compound represented by the above formula (A). R1 and R111 in the above formula (A) are preferably each independently an ether. Key or ester bond. The direction of the ester bond is not limited. As R11, an alkylene group having 2 to 4 carbon atoms is preferred. As the RIV, a single bond or a methylene group is preferred. The steroid skeleton in X of the above formula (A) means a skeleton in which one or more of the cyclopentane-perhydrophenanthrene skeleton or the carbon-carbon bond contained therein is changed to a double bond. Examples of the X group having such a skeleton are, for example, groups represented by the following formulae (X-1) to (X-4).

-13- 201001029-13- 201001029

(X-3) X1(X-3) X1

(X4) (上述式中的X1,各自表示下述式任一者表示的基團, * ”表示爲連接鍵),(X4) (X1 in the above formula each represents a group represented by any one of the following formulae, *" represents a linkage bond),

(上述式中的“ + ”表示爲連接鍵)。 作爲X基團的具體例子,可以列舉例如下述式(X - 1 —1)、(X— 2—1)、(X— 3 — 1)或(X_4 — 1)表示的基團, -14- 201001029("+" in the above formula is expressed as a connection key). Specific examples of the X group include a group represented by the following formula (X-1 - 1), (X-2 - 1), (X-3 - 1) or (X_4 - 1), -14 - 201001029

(上述式中的表示爲連接鍵)。 作爲上述式(A)表示的化合物的具體例子,可以列舉例 如下述式(A-1)〜(A〜29)各自表示的化合物。 -15- 201001029(Expressed in the above formula is a connection key). Specific examples of the compound represented by the above formula (A) include compounds represented by the following formulas (A-1) to (A to 29). -15- 201001029

n2 2 N c 2 2 o-户 ^ο Η Η ο \I/ 99?c ^—广N2 2 N c 2 2 o-house ^ο Η ο ο \I/ 99?c ^-wide

(A-2 )(A-2)

2 0 2 2 o— c 〇Η H〇 CJCICIC2 0 2 2 o— c 〇Η H〇 CJCICIC

(A-4) -16 - 201001029(A-4) -16 - 201001029

2 2 2 2 Η Η Η H o—cl etc· CIO2 2 2 2 Η Η Η H o-cl etc. CIO

(A-5 )(A-5)

(A-7 )(A-7)

(A-9)(A-9)

201001029201001029

ch2 ch2 ch2 ch2 ocoCh2 ch2 ch2 ch2 oco

(A-15 )(A-15)

-18- 201001029-18- 201001029

-19- 201001029 2-19- 201001029 2

,02 2 2 〇 l ο Η Η Η o 9C-C-C 丨 c, 02 2 2 〇 l ο Η Η Η o 9C-C-C 丨 c

(A-27 )(A-27)

-20- 201001029-20- 201001029

CH, CH2 ch2 o —γΝΗ2 ( A-29 ) NH2 這些化合物可以通過有機化學的常規方法合成。 例如上述式(A — 1)、(A — 2) ' (A - 7)或(A — 8)表示的 化合物,分別可以通過在膽甾醇或膽甾烷醇上加成號拍酸 酐後,用二氯亞颯等製成醯氯化物,將該醯氯化物在當量 以上鹼的存在下使醯氯化物與二硝基酚進行反應後,用氯 化錫等適當的還原劑進行還原而合成。 上述式(A — 3)、(A - 4)、(A — 9)或(A - 10)表示的化合 物,分別可以通過在膽甾醇或膽甾烷醇上加成琥珀酸酐 後,在碳酸鉀的存在下使上述加成物與二硝基苯甲醯氯進 行酯形成反應,然後用氯化錫等適當的還原劑進行還原而 合成。 上述式(A — 5)或(A — 1 1)表示的化合物,分別可以通過 將膽甾醇或膽甾烷醇用甲苯磺醯氯等進行甲苯磺醯化,將 所得的甲苯磺醯化膽甾醇或甲苯磺醯化膽甾烷醇與二硝基 苯甲醯氯和過量的丁二醇在鹼的存在下反應合成’得到二 硝基苯甲醯基單丁二醇酯後,與之前的甲苯磺醯化膽甾烷 醇在適當的有機溶劑中加熱形成醚鍵’然後用氯化錫等適 -21- 201001029 當的還原劑進行還原的方法合成。 上述式(A - 6)或(A- 12)表示的化合物, 在膽甾醇或膽甾烷醇上加成琥珀酸酐後,用 上述加成物的羰基還原成亞甲基,然後在三 鹼的存在下使上述還原物與2,4-二硝基氯苯 應後,用氯化錫等適當的還原劑進行還原的: 將上述同樣地製得的甲苯磺醯化膽甾醇 膽甾烷醇,與由2,4 -二硝基氯苯和過量的丁 氧基鉀等鹼的存在下反應所製得的1-(4-羥羞 二硝基苯,在適當的有機溶劑中加熱形成醚 錫等適當的還原劑進行還原的方法等而合成 上述式(A — 13)表示的化合物,可以通過 樣地製得的甲苯磺醯化膽甾烷醇,與由2,4-過量的乙二醇在三級丁氧基鉀等鹼的存在下 1-(4-羥基乙氧基)-2,4-二硝基苯,在適當的有 形成醚鍵後,用氯化錫等適當的還原劑進行 合成。 上述式(A — 14)、(A — 15)或(A— 16)表示 了分別採用羊毛甾醇、麥角甾醇或光甾醇作 外,可以按照合成上述式(A - 6)表示的化合 合成。 上述式(A — 17)或(A - 18)表示的化合物 過將膽甾醇或膽甾烷醇用甲磺醯氯進行甲磺 量的乙二醇進行置換反應合成單醚化合物, 分別可以通過 氫化鋁鋰等將 級丁氧基鉀等 進行酯形成反 方法,或者 或甲苯磺醯化 二醇在三級丁 G丁氧基)-2,4_ 鍵後,用氯化 〇 例如將上述同 二硝基氯苯和 反應所製得的 機溶劑中加熱 還原的方法而 的化合物,除 爲起始物質以 物的方法進行 ,分別可以通 醯化後,用過 然後在鹼的存 -22- 201001029 在下使上述單醚化合物與3,5-二硝基苯甲醯氯反應合成二 硝基化物後,將硝基用鈀碳等適當的還原劑進行還原而製 得。 上述式(A - 19)或(A — 20)表示的化合物,分別可以通 過將膽甾醇或膽甾烷醇用氫化鉀等製成醇鹽後,使其與過 量的二溴丙烷反應形成醚鍵製得中間體,然後在碳酸鉀的 存在下使上述中間體與3,5-二硝基苯甲酸反應合成二硝基 化物後,將硝基用鈀碳等適當的還原劑進行還原而製得。 上述式(A - 21)或(A— 22)表示的化合物,分別可以通 過在膽甾醇或膽甾烷醇上加成琥珀酸酐後,採用N,N-二環 己基碳化二亞胺使其與 3,5-(N,N-二烯丙基)胺基苯酚反 應,然後用1,3-二甲基巴比妥酸和肆(三苯基膦)鈀除去烯 丙基而製得。 上述式(A— 23)或(A- 24)表示的化合物,分別可以通 過在膽甾醇或膽甾烷醇上加成琥珀酸酐後,採用硼烷-氧 橋配合物將羰基還原製得醇中間體後,在鹼的存在下使上 述中間體與3,5·二硝基苯甲醯氯反應合成二硝基化物,然 後將硝基用鈀碳等適當的還原劑進行還原而製得。 上述式(A— 25)或(A— 26)表示的化合物,除了採用戊 二酐代替琥珀酸酐以外,可以分別與上述式(A- 4)或(A-1 0)表示的化合物同樣地製得。CH, CH2 ch2 o - γ ΝΗ 2 ( A-29 ) NH2 These compounds can be synthesized by a conventional method of organic chemistry. For example, the compound represented by the above formula (A-1), (A-2) '(A-7) or (A-8) can be used by adding an acid anhydride to cholesterol or cholestyl alcohol, respectively. Dichlorohydrazine or the like is produced as a ruthenium chloride, and the ruthenium chloride is reacted with dinitrophenol in the presence of an equivalent amount or more of a base, and then reduced by a suitable reducing agent such as tin chloride to be synthesized. The compound represented by the above formula (A-3), (A-4), (A-9) or (A-10) may be respectively added to succinic anhydride on cholesterol or cholestyl alcohol in potassium carbonate. In the presence of the above, the adduct is subjected to an ester formation reaction with dinitrobenzidine chloride, and then synthesized by reduction with an appropriate reducing agent such as tin chloride. The compound represented by the above formula (A-5) or (A-1 1) can be obtained by toluene sulfonation of cholesterol or cholestyl alcohol with toluene sulfonium chloride or the like, respectively, and the resulting toluene sulfonated cholesteryl alcohol Or toluene sulfonated cholesteryl alcohol and dinitrobenzhydryl chloride and excess butane diol are reacted in the presence of a base to synthesize 'after obtaining dinitrobenzhydryl monobutylene glycol ester, with the previous toluene The sulfonated cholesteryl alcohol is heated in an appropriate organic solvent to form an ether bond, which is then synthesized by a method such as tin chloride or the like as a reducing agent. a compound represented by the above formula (A-6) or (A-12), after addition of succinic anhydride to cholesterol or cholesterol, is reduced to a methylene group by a carbonyl group of the above adduct, and then to a tribasic In the presence of the reduced product and 2,4-dinitrochlorobenzene, the reduction is carried out with a suitable reducing agent such as tin chloride: the toluenesulfonyl cholesteryl chethol prepared in the same manner as above, 1-(4-hydroxydinitrobenzene) obtained by the reaction with a base such as 2,4-dinitrochlorobenzene and an excess of potassium butoxide, heated in a suitable organic solvent to form ether tin The compound represented by the above formula (A-13) can be synthesized by a method such as reduction by a suitable reducing agent, and the toluenesulfonated cholesteryl alcohol which can be obtained by the sample, and the ethylene glycol derived from 2, 4-excess 1-(4-hydroxyethoxy)-2,4-dinitrobenzene in the presence of a base such as potassium butoxide or the like, and an appropriate reducing agent such as tin chloride after appropriate formation of an ether bond The above formula (A-14), (A-15) or (A-16) indicates that lanosterol, ergosterol or sterol can be used as the external, respectively. The compound represented by the above formula (A-6). The compound represented by the above formula (A-17) or (A-18) is an ethylene glycol in which the amount of methyl sulfonate is determined by using cholesteryl chloride or cholesteryl chloride. The monoether compound is synthesized by a displacement reaction, and the potassium butoxide or the like may be subjected to an ester formation reverse method by lithium aluminum hydride or the like, or the toluenesulfonated diol may be in the third-order G-butoxy group - 2, 4 _ bond. Then, using a ruthenium chloride, for example, a compound obtained by heating and reducing the above-mentioned homonitrobenzene benzene and an organic solvent obtained by the reaction is removed as a starting material by an object, and each of them can be pulverized. After the above reaction, the above monoether compound is reacted with 3,5-dinitrobenzimidyl chloride to synthesize the dinitrate, and the nitro group is reduced with a suitable reducing agent such as palladium carbon. And made. The compound represented by the above formula (A-19) or (A-20) can be formed into an ether bond by reacting cholesterol or cholesterol with potassium hydride or the like to form an ether bond with an excess of dibromopropane. The intermediate is prepared, and then the intermediate is reacted with 3,5-dinitrobenzoic acid in the presence of potassium carbonate to synthesize a dinitrate, and then the nitro group is reduced with a suitable reducing agent such as palladium carbon. . The compound represented by the above formula (A-21) or (A-22) can be respectively obtained by adding N,N-dicyclohexylcarbodiimide to succinic anhydride on cholesterol or cholesteryl alcohol. The reaction of 3,5-(N,N-diallyl)aminophenol is carried out by removing the allyl group with 1,3-dimethylbarbituric acid and hydrazine (triphenylphosphine)palladium. The compound represented by the above formula (A-23) or (A-24) can be obtained by reducing a carbonyl group by using a borane-oxy bridge complex after adding succinic anhydride to cholesterol or cholestyl alcohol, respectively. After the formation, the above intermediate is reacted with 3,5·dinitrobenzimidyl chloride in the presence of a base to synthesize a dinitro compound, and then the nitro group is reduced with a suitable reducing agent such as palladium carbon. The compound represented by the above formula (A-25) or (A-26) may be produced in the same manner as the compound represented by the above formula (A-4) or (A-1 0), except that glutaric anhydride is used instead of succinic anhydride. Got it.

上述式(A — 27)、(A — 28)或(A— 29)表示的化合物,除 了將原料羊毛甾醇、麥角甾醇或光甾醇用適當的氫化催化 劑進行氫化後再使用以外,可以分別與上述式(A - 1 4)、( A -23- 201001029 —15)或(A — 16)表示的化合物同樣地製得。 作爲本發明液晶配向劑中可以含有的聚醯胺酸的合成 用二胺,可以僅使用上述式(A)表示的化合物,或者也可以 將上述式(A)表示的化合物與其他的二胺一起聯用。這裏, 作爲可以與上述式(A)表示的化合物聯用的其他二胺,可以 列舉例如對苯二胺、間苯二胺、4,4 ’ -二胺基二苯基甲烷、 4,4’-二胺基二苯基乙烷、4,4’-二胺基二苯基硫醚、4,4,_二 胺基二苯基颯、3,3’-二甲基-4,4’-二胺基聯苯、4,4,-二胺 基苯甲醯苯胺、4,4’-二胺基二苯醚、ι,5-二胺基萘、2,2’-二甲基-4,4’-二胺基聯苯、2,2’-雙(三氟甲基)_4,4’_二胺基 聯苯、3,3’-雙(三氟甲基)-4,4’-二胺基聯苯、5_胺基 胺基苯基)-1,3,3-三甲基茚滿、6 -胺基-i-(4’-胺基苯 基)-1,3,3-三甲基茚滿、3,4’-二胺基二苯基醚、3,3,-二胺基 二苯酮、3,4’-二胺基二苯酮、4,4’-二胺基二苯酮、2,2-雙 [4-(4-胺基苯氧基)苯基]丙烷、2,2-雙[4-(4-胺基苯氧基)苯 基]六氟丙烷、2,2-雙(4-胺基苯基)六氟丙烷、2,2 -雙[4-(4-胺基苯氧基)苯基]颯、1,4-雙(4-胺基苯氧基)苯、1,3_雙(4_ 胺基苯氧基)苯、1,3-雙(3-胺基苯氧基)苯、9,9_雙(4-胺基 苯基)-10-氫蒽、2,7-二胺基芴、9,9-二甲基·2,7-二胺基芴、 9,9·雙(4-胺基苯基)芴、4,4’_亞甲基-雙(2_氯苯胺)' 2,2,,5,5’ -四氯-4,4’-二胺基聯苯、2,2’-二氯-4,4,-二胺基 -5,5,-二甲氧基聯苯、3,3’-二甲氧基_4,4,_二胺基聯苯、 4,4’-(對亞苯基異亞丙基)二苯胺' 4,4’-(間亞苯基異亞丙基) 二苯胺、2,2’-雙[4-(4-胺基-2-三氟甲基苯氧基)苯基]六氟 -24- 201001029 丙烷、4,4,-二胺基-2,2,-雙(三氟甲基)聯苯、4,4’-雙[(4_胺 基-2-三氟甲基)苯氧基]-八氟聯苯等芳香族二胺; 1,1-間苯二甲胺、1,3-丙二胺、丁二胺、戊二胺、己二 胺、庚二胺、辛二胺、壬二胺、1,4 -二胺基環己烷、異佛 爾酮二胺、四氫二環戊二烯二胺、六氫-4,7-甲撐茚二亞甲 基二胺、三環[6.2.1.02,7]十一碳烯二甲二胺、4,4’-亞甲基 雙(環己胺)等脂肪族二胺和脂環式二胺; 2,3-二胺基吡啶、2,6-二胺基吡啶、3,4-二胺基吡啶、 2,4-二胺基嘧啶、5,6-二胺基-2,3-二氰基吡阱、5,6-二胺基 -2,4-二羥基嘧啶、2,4-二胺基-6-二甲胺基-1,3,5-三阱、1,4-雙(3-胺基丙基)哌阱、2,4-二胺基-6-異丙氧基-1,3,5-三阱、 2,4_二胺基-6-甲氧基-1,3,5-三哄、2,4-二胺基-6-苯基 -1,3,5-三阱、2,4-二胺基-6-甲基-s-三阱、2,4-二胺基-1,3,5-三阱、4,6-二胺基-2-乙烯基-s-三畊、2,4-二胺基-5-苯基噻 唑、2,6·二胺基嘌呤、5,6-二胺基-1,3-二甲基尿嘧啶、3,5-二胺基-1,2,4-三唑、6,9-二胺基-2-乙氧基吖啶乳酸酯、3,8-二胺基-6-苯基菲啶、1,4-二胺基哌畊、3,6-二胺基吖啶、 雙(4-胺基苯基)苯基胺、3,6-二胺基咔唑、N-甲基-3,6-二胺 基味唑、N-乙基-3,6-二胺基咔唑、N-苯基-3,6-二胺基咔 唑、Ν,Ν’-雙(4-胺基苯基)聯苯胺、下述式(D — I)表示的化 合物The compound represented by the above formula (A-27), (A-28) or (A-29) may be used in addition to the use of the raw material lanosterol, ergosterol or sterol alcohol by hydrogenation with a suitable hydrogenation catalyst. The compounds represented by the above formula (A - 14), (A-23 - 201001029-15) or (A-16) are obtained in the same manner. The diamine for synthesizing polylysine which may be contained in the liquid crystal alignment agent of the present invention may be a compound represented by the above formula (A), or a compound represented by the above formula (A) may be used together with other diamines. Use together. Here, examples of the other diamine which can be used in combination with the compound represented by the above formula (A) include p-phenylenediamine, m-phenylenediamine, 4,4 '-diaminodiphenylmethane, and 4,4'. -diaminodiphenylethane, 4,4'-diaminodiphenyl sulfide, 4,4,-diaminodiphenylanthracene, 3,3'-dimethyl-4,4' -diaminobiphenyl, 4,4,-diaminobenzimidamide, 4,4'-diaminodiphenyl ether, iota, 5-diaminonaphthalene, 2,2'-dimethyl- 4,4'-diaminobiphenyl, 2,2'-bis(trifluoromethyl)-4,4'-diaminobiphenyl, 3,3'-bis(trifluoromethyl)-4,4 '-Diaminobiphenyl, 5-aminoaminophenyl)-1,3,3-trimethylindan, 6-amino-i-(4'-aminophenyl)-1,3 , 3-trimethylindan, 3,4'-diaminodiphenyl ether, 3,3,-diaminobenzophenone, 3,4'-diaminobenzophenone, 4,4' -diaminobenzophenone, 2,2-bis[4-(4-aminophenoxy)phenyl]propane, 2,2-bis[4-(4-aminophenoxy)phenyl] Hexafluoropropane, 2,2-bis(4-aminophenyl)hexafluoropropane, 2,2-bis[4-(4-aminophenoxy)phenyl]anthracene, 1,4-bis(4) -aminophenoxy)benzene, 1 3_bis(4-aminophenoxy)benzene, 1,3-bis(3-aminophenoxy)benzene, 9,9-bis(4-aminophenyl)-10-hydroquinone, 2, 7-Diaminopurine, 9,9-dimethyl-2,7-diaminoguanidine, 9,9.bis(4-aminophenyl)anthracene, 4,4'-methylene-bis ( 2_chloroaniline) '2,2,,5,5'-tetrachloro-4,4'-diaminobiphenyl, 2,2'-dichloro-4,4,-diamino-5,5 ,-dimethoxybiphenyl, 3,3'-dimethoxy-4,4,-diaminobiphenyl, 4,4'-(p-phenylene isopropylidene)diphenylamine 4, 4'-(m-phenylene isopropylidene) diphenylamine, 2,2'-bis[4-(4-amino-2-trifluoromethylphenoxy)phenyl]hexafluoro-24- 201001029 Propane, 4,4,-diamino-2,2,-bis(trifluoromethyl)biphenyl, 4,4'-bis[(4-amino-2-trifluoromethyl)phenoxy] - an aromatic diamine such as octafluorobiphenyl; 1,1-m-xylylenediamine, 1,3-propanediamine, butanediamine, pentanediamine, hexamethylenediamine, heptanediamine, octanediamine, hydrazine Diamine, 1,4 -diaminocyclohexane, isophoronediamine, tetrahydrodicyclopentadiene diamine, hexahydro-4,7-methylene dimethylene diamine, tricyclic [6.2.1.02,7] undecene dimethyl diamine, 4, 4 - an aliphatic diamine such as methylene bis(cyclohexylamine) and an alicyclic diamine; 2,3-diaminopyridine, 2,6-diaminopyridine, 3,4-diaminopyridine, 2 , 4-diaminopyrimidine, 5,6-diamino-2,3-dicyanopyrrole, 5,6-diamino-2,4-dihydroxypyrimidine, 2,4-diamino- 6-Dimethylamino-1,3,5-tri-trap, 1,4-bis(3-aminopropyl) pipe trap, 2,4-diamino-6-isopropoxy-1,3 , 5-trimole, 2,4-diamino-6-methoxy-1,3,5-triazine, 2,4-diamino-6-phenyl-1,3,5-triad , 2,4-diamino-6-methyl-s-tripper, 2,4-diamino-1,3,5-tri-trap, 4,6-diamino-2-vinyl-s - three tillage, 2,4-diamino-5-phenylthiazole, 2,6-diaminopurine, 5,6-diamino-1,3-dimethyluracil, 3,5-di Amino-1,2,4-triazole, 6,9-diamino-2-ethoxyacridine lactate, 3,8-diamino-6-phenylphenanthridine, 1,4- Diaminopiperidine, 3,6-diaminoacridine, bis(4-aminophenyl)phenylamine, 3,6-diaminocarbazole, N-methyl-3,6-diamine Gemazole, N-ethyl-3,6-diaminocarbazole, N-phenyl-3,6-diaminocarbazole, indole, Ν'-bis(4-aminophenyl)benzidine , the following A compound represented by - (I D)

H2N nh2 X1 一 R5H2N nh2 X1 a R5

(D-I 三阱、哌啶以 (式(D — I)中,R5表示選自吡啶、嘧啶 -25- 201001029 及哌畊的具有含氮原子環狀結構的1價有機基團,χ1表示 2價的有機基團)、下述式(D— II)表示的化合物’(DI tri-trap, piperidine in (Formula (D-I), R5 represents a monovalent organic group having a cyclic structure containing a nitrogen atom selected from the group consisting of pyridine, pyrimidine-25-201001029 and piperene, and χ1 represents a divalent organic group Organic group), a compound represented by the following formula (D-II)

(D-Π) (式(D — II)中,R6表示選自吡啶、嘧啶、三阱、哌啶 以及哌阱的具有含氮原子環狀結構的2價有機基團’ X2分 別表示2價的有機基團,存在的多個X2各自可以相同,也 可以不同)等分子內具有兩個一級胺基以及該一級胺基以 外的氮原子的二胺;下述式(D— ΙΠ)表示的單取代苯二胺 (但是上述式(Α)表示的化合物除外), R7—R8(D-Π) (In the formula (D-II), R6 represents a divalent organic group having a cyclic structure containing a nitrogen atom selected from the group consisting of pyridine, pyrimidine, triple trap, piperidine, and pipe trap, and X2 represents a divalent value, respectively. The organic group, the plurality of X2 present may be the same or different), and the diamine having two primary amino groups in the molecule and a nitrogen atom other than the primary amine group; represented by the following formula (D-ΙΠ) Monosubstituted phenylenediamine (except for the compounds represented by the above formula (Α)), R7-R8

(D-III ) (式(D — III)中’ R7 表示選自·〇_、_c〇〇_、_〇c〇 、 -NHCO-、_C0NH_和_c〇^ 2價有機基團,r8表示具有選 自甾體骨架、三氟甲基苯基、三氟甲氧基苯基和氟代苯基 中的基團的1價有機基團或者碳原子數爲6〜3〇的烷基); 下述式(D- IV)表示的化合物等二胺基有機矽氧烷, R9 R9 Η2Η〇Η2々 + —f。一+士|CH今 % R9 R9 (式(D — IV)中,r (D-IV ) 基,存在的多個R9各 1〜3的整數,q爲1〜(D-III) (In the formula (D-III), 'R7 represents a group selected from the group consisting of 〇_, _c〇〇_, _〇c〇, -NHCO-, _C0NH_ and _c〇^ 2 organic groups, r8 And a monovalent organic group having a group selected from the group consisting of a steroid skeleton, a trifluoromethylphenyl group, a trifluoromethoxyphenyl group, and a fluorophenyl group, or an alkyl group having 6 to 3 Å of a carbon atom) A diamine-based organooxane such as a compound represented by the following formula (D-IV), R9 R9 Η2Η〇Η2々+-f. One + 士|CH today % R9 R9 (in the formula (D - IV), r (D-IV) base, the existence of multiple R9 each 1~3 integer, q is 1~

R9各自表示碳原子數爲 各自可以相同,也可以不间 1〜20的整數);下述式(D\ -26- 201001029 各自表示的化合物等R9 each represents an integer of 1 to 20 in which the number of carbon atoms may be the same, and a compound represented by the following formula (D\-26-201001029)

H2N h2n- ch3 CH (CH2)3 CH. ^CHs ch3 cooH2N h2n- ch3 CH (CH2)3 CH. ^CHs ch3 coo

(D-2) ch3 rH I /CH3 pH (CH2)3 CH、(D-2) ch3 rH I /CH3 pH (CH2)3 CH,

合。-O h2n^=Hehe. -O h2n^=

o—(-c2h4-o^o—(-c2h4-o^

(D-4) ch3 (D-3) ^νη2 -s- (D-5) (式(D— 4)中的y爲2〜12的整數,式(D— 5)中的z爲 -27- 201001029 1〜5的整數)° 上述芳香族一胺、分子內具有兩個—級胺基以及該一 級胺基以外的氮原子的二胺、單取代苯二胺(但是上述式(A) 表示的化合物除外)以及上述式(D - 1)〜(D〜5 )表示的化 合物所含有的苯環’任選可被碳原子數爲1〜4的烷基(較 佳甲基)取代。 在本發明液晶配向劑中可以含有的聚醯胺酸的合成 時,與上述式(A)表示的化合物一起聯用的其他二胺,較佳 含有選自上述二胺中的對苯二胺、4,4’·二胺基二苯甲烷、 4,4,-二胺基二苯硫醚、1,5-二胺基萘、2,2’-二甲基-4,4’-二胺基聯苯、2,2,-雙(三氟甲基)-4,4’-二胺基聯苯、2,7-二 胺基芴、4,4’-二胺基二苯基醚、2,2-雙[4-(4-胺基苯氧基) 苯基]丙烷、9,9-雙(4-胺基苯基)芴、2,2-雙[4-(4-胺基苯氧 基)苯基]六氟丙烷、2,2-雙(4-胺基苯基)六氟丙烷、4,4’-(對 亞苯基二異亞丙基)雙苯胺、4,4’-(間亞苯基二異亞丙基)雙 二苯胺、1,4-環己烷二胺、4,4,-亞甲基雙(環己胺)、1,4-雙 (4-胺基苯氧基)苯、4,4,-雙(4 -胺基苯氧基)聯苯、上述式(D 一 1)〜(D — 5)各自表示的化合物、2,6-二胺基吡啶' 3,4-二 胺基吡啶、2,4 -二胺基嘧啶、3,6 -二胺基吖啶、3,6 _二胺基 咔唑、N -甲基_3,6 -二胺基咔唑、N -乙基·3, 6_二胺基咔唑、 Ν-苯基-3,6-二胺基咔唑、Ν,Ν,-雙(4-胺基苯基)聯苯胺、上 述式(D - I)表示的化合物中的下述式(D - 6)表示的化合 物、上述式(D — II)表示的化合物中的下述式(D — 7)表示的 化合物、 -28- 201001029(D-4) ch3 (D-3) ^νη2 -s- (D-5) (where y in the formula (D-4) is an integer of 2 to 12, and z in the formula (D-5) is -27 - 201001029 Integer of 1 to 5) ° The above aromatic monoamine, diamine or monosubstituted phenylenediamine having two -amino groups in the molecule and a nitrogen atom other than the primary amine group (but the above formula (A) represents The benzene ring ' contained in the compound represented by the above formula (D-1) to (D~5) may be optionally substituted with an alkyl group (preferably a methyl group) having 1 to 4 carbon atoms. In the synthesis of the polyamic acid which may be contained in the liquid crystal alignment agent of the present invention, the other diamine used in combination with the compound represented by the above formula (A) preferably contains p-phenylenediamine selected from the above diamines. 4,4'-diaminodiphenylmethane, 4,4,-diaminodiphenyl sulfide, 1,5-diaminonaphthalene, 2,2'-dimethyl-4,4'-diamine Biphenyl, 2,2,-bis(trifluoromethyl)-4,4'-diaminobiphenyl, 2,7-diaminopurine, 4,4'-diaminodiphenyl ether, 2,2-bis[4-(4-aminophenoxy)phenyl]propane, 9,9-bis(4-aminophenyl)anthracene, 2,2-bis[4-(4-amino) Phenoxy)phenyl]hexafluoropropane, 2,2-bis(4-aminophenyl)hexafluoropropane, 4,4'-(p-phenylene diisopropylidene)diphenylamine, 4,4 '-(m-phenylene diisopropylidene) bisdiphenylamine, 1,4-cyclohexanediamine, 4,4,-methylenebis(cyclohexylamine), 1,4-bis(4- Aminophenoxy)benzene, 4,4,-bis(4-aminophenoxy)biphenyl, a compound represented by the above formula (D-1) to (D-5), 2,6-diamine Pyridine '3,4-diaminopyridine, 2,4-diaminopyrimidine, 3,6-diaminoacridine, 3,6-diaminocarbazole, N-methyl-3,6-diaminocarbazole, N-ethyl-3,6-diaminocarbazole, oxime-phenyl-3,6-di A compound represented by the following formula (D-6) in the compound represented by the above formula (D-1), the above formula (D), an aminocarbazole, an anthracene, an anthracene, a bis(4-aminophenyl)benzidine, or a compound represented by the above formula (D - I) - Compound represented by the following formula (D-7) in the compound represented by II), -28- 201001029

(D-6)(D-6)

h2n-^)-(^-c3h6—^n-^-nh2 (D 以及上述式(D — III)表示的化合物中的十二 -2,4-二胺基苯、十五烷氧基-2,4-二胺基苯、十六 -2,4-二胺基苯、十八烷氧基-2,4-二胺基苯、十二 -2,5 -二胺基苯、十五烷氧基-2,5 -二胺基苯、十六 -2,5-二胺基苯、十八烷氧基-2,5-二胺基苯和下述式 〜(D — 1 6) h2n—0 NH2 (D-8) -7)) 烷氧基 院氧基 院氧基 院氧基 (D- 8)H2n-^)-(^-c3h6-^n-^-nh2 (D and twelve-2,4-diaminobenzene, pentadecyloxy-2 in the compound represented by the above formula (D-III)) ,4-diaminobenzene, hexadecanol-2,4-diaminobenzene, octadecyloxy-2,4-diaminobenzene, dodeca-2,5-diaminobenzene, pentadecane Oxy-2,5-diaminobenzene, hexadecanol-2,5-diaminobenzene, octadecyloxy-2,5-diaminobenzene and the following formula ~(D-1 6) h2n —0 NH2 (D-8) -7)) alkoxy alkoxyl alkoxy (D-8)

-29- 201001029-29- 201001029

-30- 201001029-30- 201001029

各自表示的化合物構成的群組中選出的至少-爲“其他特定二胺”)的二胺。 本發明液晶配向劑中可以含有的聚醯胺酸 用的二胺,較佳相對於全部二胺,含有1莫ί 式(Α)表示的化合物,更佳爲含有2〜20莫耳°/ 有5〜1 0莫耳°/〇。 本發明液晶配向劑中可以含有的聚醯胺酸 用的二胺,較佳相對於全部二胺,進一步含有 %如上所述的其他特定二胺,更佳爲含有5 0〜 特佳爲含有80〜99莫耳%。 -種(以下稱 的合成中所 f %以上上述 »,特佳爲含 的合成中所 20〜99莫耳 9 9莫耳%, -31 - 201001029 [聚醯胺酸的合成] 本發明液晶配向劑中可以含有的聚醯胺酸,可以 使如上所述的四羧酸二酐與二胺反應而製得。 供給聚醯胺酸合成反應的四羧酸二酐與二胺化合 使用比率,較佳相對於二胺化合物中所含的1當量胺 使四羧酸二酐的酸酐基爲0.2〜2當量的比率,更佳使 0.3〜1.2當量的比率❶ 聚醯胺酸的合成反應,在有機溶劑中,較佳於-20 -°C、更佳於0〜100 °C的溫度條件下進行,反應時間較 1〜240小時,更佳爲2〜1 2小時。這裏,作爲有機溶 只要是能夠溶解合成的聚醯胺酸的溶劑,則對其沒有 的限制,可以列舉例如N -甲基-2 -吡咯烷酮、N , N -二甲 醯胺、N,N-二甲基甲醯胺、二甲基亞颯、r-丁內酯、 基脲、六甲基磷醯三胺等非質子類極性溶劑;間甲基 二甲苯酚、苯酚、鹵代苯酚等酚類溶劑。另外,有機 的用量(a)(其中當有機溶劑與下述不良溶劑聯用時,是 們的合計量),較佳爲使四羧酸二酐和二胺化合物的總 相對於反應溶液的總量(a + b)爲0. 1〜30重量%的量。 上述有機溶劑中,在不使生成的聚醯胺酸析出的 內,還可以聯用聚醯胺酸的不良溶劑醇類、酮類、酯 醚類、鹵代烴類、烴類等。作爲這種不良溶劑的具體便 可以列舉例如甲醇、乙醇、異丙醇、環己醇、乙二醇 二醇、1,4-丁二醇、三甘醇、乙二醇單甲醚、乳酸乙 乳酸丁酯、丙酮、甲基乙基酮、甲基異丁基酮、環己 通過 物的 基, 其爲 “ 150 佳爲 劑, 特別 基乙 四甲 酚、 溶劑 指它 S (b) 範圍 類、 丨子, 、丙 酯、 酮、 -32- 201001029 醋酸甲酯、醋酸乙酯、醋酸丁酯、甲氧基丙酸甲酯、乙氧 基丙酸乙酯、草酸二乙酯、丙二酸二乙酯、乙醚、乙二醇 甲醚、乙二醇乙醚、乙二醇正丙醚、乙二醇異丙醚、乙二 醇正丁醚、乙二醇二甲基醚、乙二醇乙醚乙酸酯、二甘醇 二甲醚、二甘醇二乙醚、二甘醇單甲醚、二甘醇單乙醚、 二甘醇單甲醚乙酸酯、二甘醇單乙醚乙酸酯、四氫呋喃、 二氯甲烷、1,2-二氯乙烷、1,4-二氯丁烷、三氯乙烷、氯苯、 鄰二氯苯、己烷、庚烷、辛烷、苯、甲苯、二甲苯、二異 丁基酮、丙酸異戊酯、異丁酸異戊酯、異戊醚等。 在聚醯胺酸的合成時,當將有機溶劑與不良溶劑聯用 時,不良溶劑的使用比率,相對於有機溶劑和不良溶劑的 合計量,較佳爲50重量%以下,更佳爲1 0重量%以下。 如上所述,得到溶解了聚醯胺酸的反應溶液。可以將 該反應溶液直接供給液晶配向劑的配製,也可以將反應溶 裤中所含的聚醯胺酸分離出來後供給液晶配向劑的配製, 或者也可以將分離出的聚醯胺酸精製後再供給液晶配向劑 的配製。聚醯胺酸的分離,可以通過將上述反應溶液投入 到大量的不良溶劑中’得到析出物,再減壓乾燥該析出物 的方法’或者將反應溶液用蒸發器減壓餾出的方法進行。 另外’通過進行一次或者幾次使該聚醯胺酸再次溶解於有 機溶劑中’然後用不良溶劑使其析出的方法,或用蒸發器 減壓餾出的步驟’可以精製聚醯胺酸。 [醯亞胺化聚合物] 本發明液晶配向劑中可以含有的醯亞胺化聚合物,可 -33- 201001029 以通過將如上所述的聚醯胺酸脫水閉環以醯亞胺化而製 得。 作爲醯亞胺化聚合物的合成中所用的四羧酸二酐,較 佳使用含有選自脂環式四羧酸二酐中的至少一種(以下稱 爲“特定四羧酸二酐(2)” )的四羧酸二酐。作爲特定四羧酸 二酐(2),特佳選自 2,3,5-三羧基環戊基醋酸二酐、 1,3,3&,4,5,91>-六氫-5-(四氫-2,5-二氧代-3-呋喃基)-萘 [1,2-(:]-呋喃-1,3-二酮、1,3,3&,4,5,91)-六氫-8-甲基-5-(四氫 -2,5-二氧代-3-呋喃基)-萘[l,2-c]-呋喃-1,3-二酮、3-氧雜雙 環[3.2.1]辛烷-2,4-二酮-6-螺-3’-(四氫呋喃-2’,5’-二酮)、 5-(2,5-二氧代四氫-3-呋喃基)-3-甲基-3-環己烯-1,2-二羧 酸酐、3,5,6-三羧基-2-羧基降冰片烷-2:3,5:6-二酐和4,9-二氧雜三環[5·3.1_02,6]十一烷-3,5,8,10-四酮構成的群組中 的至少一種。 本發明液晶配向劑中可以含有的醯亞胺化聚合物的合 成中所用的四羧酸二酐,較佳相對於全部四羧酸二酐,含 有20莫耳%以上如上所述的特定四羧酸二酐(2),更佳爲含 有5 0莫耳°/〇以上,特佳爲含有8 0莫耳%以上。 作爲上述醯亞胺化聚合物的合成中所用的二胺,可以 列舉與上述聚醯胺酸合成中所用的二胺相同的二胺。 上述醯亞胺化聚合物,可以是原料聚醯胺酸所具有的 醯胺酸結構全部脫水閉環的完全醯亞胺化物,也可以是醯 胺酸結構僅一部分脫水閉環、醯胺酸結構與醯亞胺環結構 並存的部分醯亞胺化物。 -34- 201001029 本發明液晶配向劑中所含的醯亞胺化聚合物,其醯亞 胺化率較佳爲2 0 %以上,特佳爲4 0〜8 0 %。 上述醯亞胺化率,是指相對於醯亞胺化聚合物的醯胺 酸結構數與醯亞胺環結構數的合計數量,醯亞胺環結構數 所占的比率用百分率表示的値。此時,醯亞胺環的一部分 還可以是異醯亞胺環。醯亞胺化率可以通過將醯亞胺化聚 合物溶於適當的氘代溶劑(例如氘代二甲基亞颯)中,以四 甲基矽烷爲基準物質,在室溫下測定1 H-NMR,由測定結 果按照下述公式(1)求出。 醯亞胺化率(%) = (1 — AVa2x a )xl 00 (1) (公式(1)中,A1爲化學位移10 ppm附近出現的源於 NH基質子的峰面積,A2爲源於其他質子的的峰面積,α 爲相對於醯亞胺化聚合物前體(聚醯胺酸)中的1個ΝΗ基的 質子,其他質子的個數比率)。 爲了合成上述醯亞胺化聚合物的聚醯胺酸的脫水閉 環,可以(i)通過加熱聚醯胺酸的方法,或者(ii)通過將聚醯 胺酸溶解於有機溶劑中,向該溶液中加入脫水劑和脫水閉 環催化劑並根據需要加熱的方法進行。 上述(i)的加熱聚醯胺酸的方法中的反應溫度,較佳爲 50〜200 °C,更佳爲60〜170 °C。當反應溫度不足501:時, 則脫水閉環反應不能進行充分,若反應溫度超過200°C, 則會出現所得醯亞胺化聚合物的分子量下降的情況。反應 時間較佳爲1〜2 4小時,更佳爲2〜8小時。 在上述(Π)的在聚醯胺酸溶液中添加脫水劑和脫水閉 -35- 201001029 環催化劑的方法中’作爲脫水劑,可以使用例如醋酸酐、 丙酸酐、三氟乙酸酐等酸酐。脫水劑的用量,較佳相對於 聚醯胺酸的1莫耳重複單元爲0.01〜20莫耳。另外,作爲 脫水閉環催化劑’可以使用例如吡啶、三甲吡啶、二甲吡 啶、三乙胺等三級胺。但是,並不局限於這些。脫水閉環 催化劑的用量,相對於1莫耳所用脫水劑,較佳爲〇. ο 1〜 10莫耳。另外,作爲脫水閉環反應中所用的有機溶劑,可 以列舉作爲聚醯胺酸合成中所用溶劑而例示的有機溶劑。 並且,脫水閉環反應的反應溫度,較佳爲0〜180 °C,更佳 爲10〜1 50 °C,反應時間較佳爲1〜24小時,更佳爲2〜8 小時。 上述方法(i)中製得的醯亞胺化聚合物,可以將其直接 供給液晶配向劑的配製,或者也可以將製得的醯亞胺化聚 合物精製後再供給液晶配向劑的配製。另外,在上述方法 (Π)中,得到含有醯亞胺化聚合物的反應溶液。該反應溶 液’可以將其直接供給液晶配向劑的配製,也可以從反應 溶液中除去脫水劑和脫水閉環催化劑之後供給液晶配向劑 的配製’還可以將醯亞胺化聚合物分離出來後供給液晶配 向劑的配製,或者也可以將分離的醯亞胺化聚合物精製後 再供給液晶配向劑的配製。從反應溶液中除去脫水劑和脫 水閉環催化劑,可以採用例如溶劑置換等方法。醯亞胺化 聚合物的分離、精製,可以採取與以上作爲聚醯胺酸的分 離、精製方法所描述的同樣的操作而進行。 -末端修飾型的聚合物- -36- 201001029 本發明液晶配向劑中可以含有的聚醯胺酸或其醯亞胺 化聚合物還可以是進行了分子量調節的末端修飾型聚合 物。通過使用末端修飾型的聚合物,可以在不損害本發明 效果的前提下進一步改善液晶配向劑的塗敷性能等。這種 末端修飾型聚合物可以通過在聚醯胺酸的合成時,向聚合 反應體系中加入分子量調節劑而進行。作爲分子量調節 劑,可以列舉單酐、單胺化合物、單異氰酸酯化合物等。 作爲上述單酐,可以列舉例如馬來酸酐、鄰苯二甲酸 酐、衣康酸酐、正癸基琥珀酸酐、正十二烷基琥珀酸酐、 正十四烷基琥珀酸酐、正十六烷基琥珀酸酐等。作爲上述 單胺化合物,可以列舉例如苯胺、環己胺、正丁胺、正戊 胺、正己胺、正庚胺、正辛胺、正壬胺、正癸胺、正十一 烷胺、正十二烷胺、正十三烷胺、正十四烷胺、正十五烷 胺、正十六烷胺、正十七烷胺、正十八烷胺、正二十烷胺 等。作爲上述單異氰酸酯化合物,可以列舉例如異氰酸苯 酯、異氰酸萘基酯等。 分子量調節劑的使用比率,相對於100重量份聚醯胺 酸合成時所使用的四羧酸二酐和二胺的合計量,較佳爲20 重量份以下,更佳爲5重量份以下。 -溶液黏度- 如上製得的聚醯胺酸或醯亞胺化聚合物,較佳當配成 濃度爲10重量%的溶液時,具有20〜800 mPa.s的溶液黏 度,更佳具有30〜500 mPa's的溶液黏度。 上述聚合物的溶液黏度(mPa.s),是對採用該聚合物的 -37- 201001029 良溶劑(例如r -丁內酯、N-甲基-2-吡咯烷酮等)配成的10 重量%濃度的聚合物溶液,用E型旋轉黏度計在2 5 °C下測 定的値。 <其他添加劑> 本發明的液晶配向膜含有選自如上所述的聚醯胺酸及 其脫水閉環而製得的醯亞胺化聚合物構成的群組中的至少 一種聚合物作爲必需成分,並根據需要還可以含有其他成 分。作爲這種其他成分,可以列舉例如分子內具有至少1 個環氧基的化合物(以下稱爲“環氧基化合物”)、官能性 矽烷化合物等。 作爲上述環氧基化合物,較佳的可以列舉例如乙二醇 二縮水甘油醚、聚乙二醇二縮水甘油醚、丙二醇二縮水甘 油醚、三丙二醇二縮水甘油醚、聚丙二醇二縮水甘油醚、 新戊二醇二縮水甘油醚、1,6·己二醇二縮水甘油醸、甘油 二縮水甘油醚、2,2-二溴新戊二醇二縮水甘油醚、1,3,5,6-四縮水甘油基- 2,4-己二醇、N,N,N’,N’-四縮水甘油基-間苯 二甲胺、1,3-雙(Ν,Ν-二縮水甘油基胺基甲基)環己烷、 Ν,Ν,Ν’,Ν’-四縮水甘油基- 4,4’-二胺基二苯基甲烷、Ν,Ν-二 縮水甘油基-苄胺、Ν,Ν-二縮水甘油基-胺基甲基環己烷 等。這些含環氧基化合物的混合比率,相對於100重量份 聚合物的合計量(是指液晶配向劑中所含的聚醯胺酸及其 醯亞胺化聚合物的合計量。下同),較佳爲40重量份以下, 更佳爲0.1〜30重量份。 作爲上述官能性矽烷化合物,可以列舉例如3 -胺基丙 -38- 201001029 基三甲氧基矽烷、3-胺基丙基三乙氧基矽烷、2-胺基丙基 三甲氧基矽烷、2-胺基丙基三乙氧基矽烷、N-(2-胺基乙 基)-3-胺基丙基三甲氧基矽烷、Ν·(2-胺基乙基)-3-胺基丙基 甲基二甲氧基矽烷、3-脲基丙基三甲氧基矽烷、3-脲基丙 基三乙氧基矽烷、N-乙氧羰基-3-胺基丙基三甲氧基矽烷、 N-乙氧羰基-3-胺基丙基三乙氧基矽烷、N-三乙氧基矽烷基 丙基三亞乙基三胺、N-三甲氧基矽烷基丙基三亞乙基三 胺、10 -三甲氧基矽烷-1,4,7 -三氮雜癸烷、10 -三乙氧基矽 烷基-1,4,7-三氮雜癸烷、9-三甲氧基矽烷基-3,6-二氮雜壬 基乙酸酯、9-三乙氧基矽烷基-3,6-二氮雜壬基乙酸酯、N-苄基-3-胺基丙基三甲氧基矽烷、N-苄基-3-胺基丙基三乙氧 基矽烷、N-苯基-3-胺基丙基三甲氧基矽烷、N-苯基-3-胺基 丙基三乙氧基矽烷、N-雙(氧乙烯基)-3-胺基丙基三甲氧基 矽烷、N-雙(氧乙烯基)-3-胺基丙基三乙氧基矽烷等。 這些含官能性矽烷化合物的混合比率,相對於100重 量份聚合物合計量,較佳爲40重量份以下。 本發明的液晶配向劑是將選自如上所述的聚醯胺酸及 其醯亞胺化聚合物構成的群組中的至少一種聚合物以及根 據需要任選配合的其他添加劑較佳溶解含於有機溶劑中而 構成的。 作爲本發明液晶配向劑中可以使用的有機溶劑,可以 列舉作爲聚醯胺酸合成反應中所用的溶劑而例示的溶劑。 另外,還可以適當地選擇聯用作爲聚醯胺酸的合成反應時 可聯用的而例示的不良溶劑。作爲這種有機溶劑的較佳例 -39- 201001029 子’可以列舉例如N -甲基-2-耻略院酮、7 •丁內醋、丁 內醯胺、Ν,Ν -二甲基甲醯胺、ν,Ν -二甲基乙醯胺、4 -羥基 -4-甲基-2-戊酮、乙二醇單甲醚、乳酸丁酯、乙酸丁酯、甲 氧基丙酸甲酯、乙氧基丙酸乙酯、乙二醇甲醚、乙二醇乙 醚、乙二醇正丙醚、乙二醇異丙醚、乙二醇正丁醚(丁基溶 纖劑)、乙二醇二甲基醚、乙二醇乙醚乙酸酯、二甘醇二甲 醚、二甘醇二乙醚、二甘醇單甲醚、二甘醇單乙醚、二甘 醇單甲醚乙酸酯、二甘醇單乙醚乙酸酯、二異丁基酮、丙 酸異戊酯、異丁酸異戊酯、異戊醚等。它們可以單獨使用, 或者也可以兩種以上混合使用。 本發明液晶配向劑中固體含量濃度(液晶配向劑中除 有機溶劑以外的成分的合計重量占液晶配向劑總重量的比 率)考慮黏性、揮發性等而適當地選擇,較佳爲1〜10重量 %的範圍。也就是說,本發明的液晶配向劑,將其塗敷於 基板表面,除去有機溶劑,形成作爲液晶配向膜的塗膜, 當固體含量濃度不足1重量%時,將出現該塗膜的厚度過 小而難以獲得良好的液晶配向膜的情況:另一方面,當固 體含量濃度超過10重量%時,將出現塗膜厚度過厚而同樣 難以獲得良好的液晶配向膜的情況,並且,出現液晶配向 劑的黏性增大,導致塗敷性能變差的情況。 特佳的固體含量濃度範圍,根據將液晶配向劑塗敷於 基板時所採用的方法而不同。例如,當採用旋塗法時’特 佳1 . 5〜4.5重量%的範圍。當採用印刷法時,特佳使固體 含量濃度爲3〜9重量%的範圍,這樣,可以使溶液黏度落 -40- 201001029 在12〜50 mPa.s的範圍。當採用噴墨法時’特佳使固體含 量濃度爲1〜5重量%的範圍,這樣,可以使溶液黏度落在 3〜15 mPa‘s的範圍。 <液晶顯示元件> 本發明的液晶顯示元件具有由如上所述的本發明液晶 配向劑形成的液晶配向膜。 本發明的液晶顯示元件可以通過例如以下的方法製 造。 (1)採用例如輥塗法、旋塗法、印刷法、噴墨法等方法, 將本發明的液晶配向劑塗敷於設有形成圖案的透明導電膜 的基板一面上,接著,通過加熱塗敷面形成塗膜。這裏, 作爲基板,可以使用例如浮法玻璃、鈉鈣玻璃等玻璃;聚 對苯二甲酸乙二醇酯、聚對苯二甲酸丁二醇酯、聚醚碾、 聚碳酸酯、脂環式聚烯烴等塑膠製透明基板。作爲基板一 面上設置的透明導電膜,可以使用氧化錫(Sn02)製的NESA 膜(美國PPG公司註冊商標)、氧化銦-氧化錫(In2〇3 — Sn〇2) 製的ITO膜等。形成圖案的透明導電膜的製得,可採用例 如在基板上形成無圖案的透明導電膜後,通過光刻蝕形成 所需圖案的方法’在透明導電膜形成時,採用具有所需圖 案的光罩’直接形成圖案狀的透明導電膜的方法等。在塗 敷液晶配向劑時’爲了進一步改善基板表面與樹脂膜的黏 附性,還可以預先塗敷例如官能性矽烷化合物、官能性鈦 化合物等。液晶配向劑塗敷後,爲了防止塗敷的配向劑液 體下垂等的目的,較佳進行預加熱(預烘焙)。預烘焙溫度 -41 - 201001029 較佳爲30〜200 °C,更佳爲40〜150。〇,特佳40〜100。(:。 預烘焙時間較佳爲0.1〜10分鐘,更佳爲0.5〜3分鐘。然 後’爲了完全除去溶劑等目的,進行燒成(後烘焙)步驟。 該後烘焙溫度較佳爲80〜300 °C,更佳爲120〜250 °C。後 供培時間較佳爲1〜180分鐘,更佳爲10〜120分鐘。 本發明的液晶配向劑通過塗敷後除去有機溶劑而形成 作爲配向膜的塗膜,而當本發明的液晶配向劑中所含的聚 合物爲聚醯胺酸或者同時存在醯亞胺環結構和醯胺酸結構 的醯亞胺化聚合物時,還可以在形成塗膜後通過進一步加 熱使其進行脫水閉環反應,以形成進一步醯亞胺化的塗膜。 這晏形成的塗膜的厚度,較佳爲0.001〜Ιμιη,更佳爲 0.005 〜0.5μπι。 (2)預製兩塊如上形成液晶配向膜的基板,通過在該兩 塊基板間佈置液晶,製造液晶胞。液晶胞的製造,可以列 舉例如以下的兩種方法。 第一種方法,是以前已知的方法。首先,通過將兩塊 基板通過間隙(胞間隙)相對設置,使各自的液晶配向膜相 對向,將兩塊基板的周邊部位用密封劑貼合,向由基板表 面和密封劑圍成的胞間隙內塡充液晶後,封閉注入孔,即 可製得液晶胞。 第二種方法,是被稱作爲〇DF(One Dr〇p Fill)方式的 方法。在形成液晶配向膜的兩塊基板中的一塊基板上的規 定部位,塗敷例如紫外線固化性密封劑材料,再在液晶配 向膜面上滴下液晶後,貼合另一塊基板,使液晶配向膜向 -42- 201001029 對向’然後對基板整面照射紫外線,使密封劑固化,即可 製得液晶胞。本發明的液晶配向劑,由於能夠形成垂直配 向性優良的液晶配向膜’因而具有即使採用〇Df方法製造 VA型液晶顯示元件時,也能夠製得不會產生〇df不勻的 液晶顯示元件的優點。 在採用任一方法的情況下,均需要通過接著將液晶胞 加熱至所用液晶呈各向同性相的溫度後,緩慢冷卻至室 溫,來除去注入時的流動配向。 然後’通過在液晶胞的外側表面上貼合偏光板,即可 製得本發明的液晶顯示元件。 這裏’作爲密封劑,可以使用例如含作爲固化劑和分 隔物的氧化鋁球的環氧樹脂等。 作爲液晶’可以列舉向列型液晶和碟狀型液晶。其中 較佳爲向列型液晶’可以使用例如希夫氏鹼類液晶、氧化 偶氮基類液晶、聯苯類液晶、苯基環己烷類液晶、酯類液 晶、三聯苯類液晶、聯苯基環己烷類液晶、嘧啶類液晶、 二氧六環類液晶、雙環辛烷類液晶、立方烷類液晶等。並 且,這些液晶中還可以進一步添加例如氯化膽甾醇、膽甾 醇壬酸酯、膽甾醇碳酸酯等膽甾型液晶或以商品名 “C-15” 、 “CB-15”(MERCK公司製)銷售的手性劑等而 進行使用。並且,還可以使用對癸氧基苯亞甲基-對胺基-2-甲基丁基肉桂酸酯等鐵電性液晶。 另外,作爲液晶胞外表面上貼合的偏光板,可以列舉 將聚乙烯醇延伸配向同時吸收碘所得的稱作爲“H膜”的 -43- 201001029 偏光膜夾在醋酸纖維保護膜中而製成的偏光板或者Η膜自 身製成的偏光板。 [實施例] 實施例1(上述式(Α— 10)表示的化合物的合成) 上述式(Α— 10)表示的化合物(以下稱爲“化合物(Α-10)”)按照下述合成路線1合成。The diamines selected from the group consisting of the respective compounds are at least - "other specific diamines"). The diamine for polyglycolic acid which may be contained in the liquid crystal alignment agent of the present invention preferably contains 1 mol of a compound represented by the formula (Α), more preferably 2 to 20 mol / relative to the entire diamine. 5 to 1 0 Moh ° / 〇. The diamine for polyphthalic acid which may be contained in the liquid crystal alignment agent of the present invention preferably further contains % of the other specific diamine as described above with respect to all the diamines, more preferably 50% to 80%. ~99 moles %. - (hereinafter referred to as f% or more in the above-mentioned synthesis), particularly preferably in the synthesis of 20 to 99 moles of 9 9 mole %, -31 - 201001029 [Synthesis of poly-proline] Liquid crystal alignment of the present invention The polyglycine which may be contained in the agent can be obtained by reacting the tetracarboxylic dianhydride with a diamine as described above. The ratio of the tetracarboxylic dianhydride to the diamine used in the synthesis reaction of the polyproline is more Preferably, the ratio of the acid anhydride group of the tetracarboxylic dianhydride to the acid anhydride group of the tetracarboxylic dianhydride is 0.2 to 2 equivalents, more preferably 0.3 to 1.2 equivalents of the ratio of the synthesis reaction of the poly-proline, in organic The solvent is preferably carried out at a temperature of -20 ° C, more preferably 0 to 100 ° C, and the reaction time is 1 to 240 hours, more preferably 2 to 12 hours. The solvent capable of dissolving the synthesized polylysine is not limited thereto, and examples thereof include N-methyl-2-pyrrolidone, N,N-dimethylguanamine, and N,N-dimethylformamide. Aprotic polar solvent such as dimethyl hydrazine, r-butyrolactone, ureido, hexamethylphosphonium triamine; m-methyl xylenol a phenolic solvent such as phenol or a halogenated phenol. Further, the organic amount (a) (wherein the organic solvent is used in combination with the following poor solvent) is preferably a tetracarboxylic dianhydride and two The amount of the total amount of the amine compound relative to the total amount of the reaction solution (a + b) is 0.1 to 30% by weight. In the above organic solvent, it is also possible to use a combination of the polyglycine which is not precipitated. Examples of the poor solvent of valine are alcohols, ketones, ester ethers, halogenated hydrocarbons, hydrocarbons, etc. Specific examples of such a poor solvent include methanol, ethanol, isopropanol, cyclohexanol, and ethylene. Alcohol diol, 1,4-butanediol, triethylene glycol, ethylene glycol monomethyl ether, butyl lactate, acetone, methyl ethyl ketone, methyl isobutyl ketone, cyclohexyl radical , which is "150 good agent, special base ethylene tetracresol, solvent refers to it S (b) range class, scorpion, propyl ester, ketone, -32- 201001029 methyl acetate, ethyl acetate, butyl acetate Methyl methoxypropionate, ethyl ethoxypropionate, diethyl oxalate, diethyl malonate, diethyl ether, ethylene glycol Methyl ether, ethylene glycol ether, ethylene glycol n-propyl ether, ethylene glycol isopropyl ether, ethylene glycol n-butyl ether, ethylene glycol dimethyl ether, ethylene glycol ethyl ether acetate, diglyme, Diethylene glycol diethyl ether, diethylene glycol monomethyl ether, diethylene glycol monoethyl ether, diethylene glycol monomethyl ether acetate, diethylene glycol monoethyl ether acetate, tetrahydrofuran, dichloromethane, 1,2-dichloro Ethane, 1,4-dichlorobutane, trichloroethane, chlorobenzene, o-dichlorobenzene, hexane, heptane, octane, benzene, toluene, xylene, diisobutyl ketone, propionic acid Amyl ester, isoamyl isobutyrate, isoamyl ether, etc. In the synthesis of polylysine, when the organic solvent is used in combination with a poor solvent, the ratio of use of the poor solvent to the total of the organic solvent and the poor solvent The amount is preferably 50% by weight or less, more preferably 10% by weight or less. As described above, a reaction solution in which polylysine was dissolved was obtained. The reaction solution may be directly supplied to the liquid crystal alignment agent, or the polylysine contained in the reaction pants may be separated and supplied to the liquid crystal alignment agent, or the separated polyamic acid may be purified. The preparation of the liquid crystal alignment agent is further supplied. The separation of the polyamic acid can be carried out by adding the above reaction solution to a large amount of a poor solvent to obtain a precipitate, and then drying the precipitate under reduced pressure or by subjecting the reaction solution to distillation under reduced pressure using an evaporator. Further, the poly-proline may be purified by a method of re-dissolving the polyamic acid in an organic solvent once or several times and then precipitating it with a poor solvent or by distilling off under reduced pressure with an evaporator. [醯i-imidized polymer] The ruthenium iodide polymer which may be contained in the liquid crystal alignment agent of the present invention may be obtained by dehydrating a polyamine acid as described above by hydrazine imidization by -33-201001029 . As the tetracarboxylic dianhydride used in the synthesis of the quinone imidized polymer, at least one selected from the group consisting of alicyclic tetracarboxylic dianhydrides (hereinafter referred to as "specific tetracarboxylic dianhydride (2)) is preferably used. ") tetracarboxylic dianhydride. As the specific tetracarboxylic dianhydride (2), it is particularly preferably selected from the group consisting of 2,3,5-tricarboxycyclopentyl acetic acid dianhydride, 1,3,3&, 4,5,91>-hexahydro-5-( Tetrahydro-2,5-dioxo-3-furanyl)-naphthalene [1,2-(:]-furan-1,3-dione, 1,3,3&, 4,5,91)- Hexahydro-8-methyl-5-(tetrahydro-2,5-dioxo-3-furanyl)-naphthalene [l,2-c]-furan-1,3-dione, 3-oxa Bicyclo[3.2.1]octane-2,4-dione-6-spiro-3'-(tetrahydrofuran-2',5'-dione), 5-(2,5-dioxotetrahydro-3 -furyl)-3-methyl-3-cyclohexene-1,2-dicarboxylic anhydride, 3,5,6-tricarboxy-2-carboxynorbornane-2:3,5:6-dianhydride And at least one of the group consisting of 4,9-dioxatricyclo[5.3.1_02,6]undecane-3,5,8,10-tetraone. The tetracarboxylic dianhydride used in the synthesis of the quinone imidized polymer which may be contained in the liquid crystal alignment agent of the present invention preferably contains 20 mol% or more of the specific tetracarboxylic acid as described above with respect to all of the tetracarboxylic dianhydride. The acid dianhydride (2) preferably contains 50 mol% or more, and particularly preferably contains 80 mol% or more. The diamine used in the synthesis of the above ruthenium iodide polymer may be the same as the diamine used in the synthesis of the above polyamic acid. The above ruthenium iodide polymer may be a complete ruthenium imide of a lysine structure in which the proline acid structure of the raw material polyamic acid has a dehydration ring closure, or a partial hydrazine ring structure, a guanine structure and a guanidine structure. Part of the quinone imine compound coexisting with the imine ring structure. -34- 201001029 The ruthenium iodide polymer contained in the liquid crystal alignment agent of the present invention preferably has a ruthenium amination ratio of 20% or more, particularly preferably 40 to 80%. The above-mentioned ruthenium amination ratio means the total amount of the structure of the guanidine imide polymer and the number of the quinone imine ring structure, and the ratio of the number of the quinone imine ring structure is expressed by a percentage. At this time, a part of the quinone ring may also be an isoindole ring. The hydrazine imidization rate can be determined by dissolving the ruthenium iodide polymer in a suitable deuterated solvent (for example, deuterated dimethyl hydrazine), using tetramethyl decane as a reference substance, and measuring 1 H- at room temperature. NMR was determined from the measurement results according to the following formula (1). Ruthenium amination rate (%) = (1 - AVa2x a )xl 00 (1) (In equation (1), A1 is the peak area derived from the NH matrix near the chemical shift of 10 ppm, and A2 is derived from other The peak area of the proton, α is the number of protons relative to the one sulfhydryl group in the ruthenium polymer precursor (polyglycolic acid), and the number of other protons). In order to synthesize the dehydration ring closure of the polyamidic acid of the above ruthenium iodide polymer, (i) by heating the polyamic acid, or (ii) by dissolving the polylysine in an organic solvent, to the solution A dehydrating agent and a dehydration ring-closing catalyst are added and heated as needed. The reaction temperature in the method of heating poly-proline in the above (i) is preferably 50 to 200 ° C, more preferably 60 to 170 ° C. When the reaction temperature is less than 501:, the dehydration ring-closure reaction cannot be sufficiently carried out. When the reaction temperature exceeds 200 ° C, the molecular weight of the obtained ruthenium-imided polymer may be lowered. The reaction time is preferably from 1 to 2 hours, more preferably from 2 to 8 hours. In the above (Π) method of adding a dehydrating agent to a polyamic acid solution and dehydrating the -35-201001029 ring catalyst, as the dehydrating agent, an acid anhydride such as acetic anhydride, propionic anhydride or trifluoroacetic anhydride can be used. The amount of the dehydrating agent is preferably 0.01 to 20 moles per 1 mole of the repeating unit of the polyglycolic acid. Further, as the dehydration ring-closure catalyst, a tertiary amine such as pyridine, trimethylpyridine, dimethylpyridine or triethylamine can be used. However, it is not limited to these. The amount of the dehydration ring-closure catalyst is preferably 〇. 〜 1 to 10 mols, relative to the dehydrating agent used in 1 mol. Further, as the organic solvent used in the dehydration ring-closure reaction, an organic solvent exemplified as a solvent used in the synthesis of polyglycolic acid can be mentioned. Further, the reaction temperature of the dehydration ring closure reaction is preferably from 0 to 180 ° C, more preferably from 10 to 150 ° C, and the reaction time is preferably from 1 to 24 hours, more preferably from 2 to 8 hours. The quinone imidized polymer obtained in the above method (i) may be directly supplied to a liquid crystal alignment agent, or may be obtained by refining the obtained quinone imidized polymer and then supplying it to a liquid crystal alignment agent. Further, in the above method (Π), a reaction solution containing a ruthenium iodide polymer is obtained. The reaction solution can be directly supplied to the liquid crystal alignment agent, or can be prepared by removing the dehydrating agent and the dehydration ring-closing catalyst from the reaction solution, and can also be supplied to the liquid crystal alignment agent. The formulation of the alignment agent or the separation of the separated ruthenium-imiding polymer may be supplied to the liquid crystal alignment agent. The dehydrating agent and the dehydration ring-closing catalyst are removed from the reaction solution, and a method such as solvent replacement can be employed. The separation and purification of the ruthenium iodide polymer can be carried out in the same manner as described above for the separation and purification method of polyglycine. - Terminal-modified polymer - 36-201001029 The poly-proline or the quinone imidized polymer which may be contained in the liquid crystal alignment agent of the present invention may be a terminal-modified polymer having a molecular weight adjusted. By using the terminal-modified polymer, the coating performance and the like of the liquid crystal alignment agent can be further improved without impairing the effects of the present invention. Such a terminal-modified polymer can be carried out by adding a molecular weight modifier to a polymerization reaction system during the synthesis of poly-proline. The molecular weight modifier may, for example, be a monoanhydride, a monoamine compound or a monoisocyanate compound. As the above-mentioned monoanhydride, for example, maleic anhydride, phthalic anhydride, itaconic anhydride, n-decyl succinic anhydride, n-dodecyl succinic anhydride, n-tetradecyl succinic anhydride, n-hexadecyl amber may be mentioned. Anhydride, etc. Examples of the above monoamine compound include aniline, cyclohexylamine, n-butylamine, n-pentylamine, n-hexylamine, n-heptylamine, n-octylamine, n-decylamine, n-decylamine, n-undecylamine, and positive ten. Dialkylamine, n-tridecylamine, n-tetradecylamine, n-pentadecylamine, n-hexadecylamine, n-heptadecaneamine, n-octadecylamine, n-icosylamine, and the like. The monoisocyanate compound may, for example, be phenyl isocyanate or naphthyl isocyanate. The use ratio of the molecular weight modifier is preferably 20 parts by weight or less, more preferably 5 parts by weight or less based on the total amount of the tetracarboxylic dianhydride and the diamine used in the synthesis of the polyglycolic acid. - Solution Viscosity - Polylysine or oxime imidized polymer prepared as above, preferably having a solution concentration of 10% by weight, having a solution viscosity of 20 to 800 mPa.s, more preferably 30~ Solution viscosity of 500 mPa's. The solution viscosity (mPa.s) of the above polymer is a concentration of 10% by weight of a good solvent (for example, r-butyrolactone, N-methyl-2-pyrrolidone, etc.) of -37-201001029 using the polymer. The polymer solution was measured by an E-type rotary viscometer at 25 ° C. <Other Additives> The liquid crystal alignment film of the present invention contains at least one polymer selected from the group consisting of polylysine as described above and a ruthenium-based polymer obtained by dehydration ring closure as an essential component And may also contain other ingredients as needed. Examples of such other components include a compound having at least one epoxy group in the molecule (hereinafter referred to as "epoxy compound"), a functional decane compound, and the like. Preferred examples of the epoxy group-containing compound include ethylene glycol diglycidyl ether, polyethylene glycol diglycidyl ether, propylene glycol diglycidyl ether, tripropylene glycol diglycidyl ether, and polypropylene glycol diglycidyl ether. Neopentyl glycol diglycidyl ether, 1,6·hexanediol diglycidyl hydrazine, glycerol diglycidyl ether, 2,2-dibromoneopentyl glycol diglycidyl ether, 1,3,5,6- Tetraglycidyl- 2,4-hexanediol, N,N,N',N'-tetraglycidyl-m-xylylenediamine, 1,3-bis(indole, fluorene-diglycidylamino Methyl)cyclohexane, hydrazine, hydrazine, hydrazine, Ν'-tetraglycidyl- 4,4'-diaminodiphenylmethane, anthracene, hydrazine-diglycidyl-benzylamine, hydrazine, hydrazine - diglycidyl-aminomethylcyclohexane or the like. The mixing ratio of these epoxy group-containing compounds is a total amount of 100 parts by weight of the polymer (refers to the total amount of the polylysine and its ruthenium iodide polymer contained in the liquid crystal alignment agent. The same applies hereinafter). It is preferably 40 parts by weight or less, more preferably 0.1 to 30 parts by weight. The functional decane compound may, for example, be 3-aminopropyl-38-201001029-based trimethoxydecane, 3-aminopropyltriethoxydecane, 2-aminopropyltrimethoxydecane, 2- Aminopropyltriethoxydecane, N-(2-aminoethyl)-3-aminopropyltrimethoxydecane, Ν(2-aminoethyl)-3-aminopropylmethyl Dimethoxyoxane, 3-ureidopropyltrimethoxydecane, 3-ureidopropyltriethoxydecane, N-ethoxycarbonyl-3-aminopropyltrimethoxydecane, N-B Oxycarbonyl-3-aminopropyltriethoxydecane, N-triethoxydecylpropyltriethylenetriamine, N-trimethoxydecylpropyltriethylenetriamine, 10-trimethoxy Cyclodecane-1,4,7-triazadecane, 10-triethoxydecyl-1,4,7-triazadecane, 9-trimethoxydecyl-3,6-diaza Heteroalkyl acetate, 9-triethoxydecyl-3,6-diazaindolyl acetate, N-benzyl-3-aminopropyltrimethoxydecane, N-benzyl- 3-aminopropyltriethoxydecane, N-phenyl-3-aminopropyltrimethoxydecane, N-phenyl-3-aminopropyltriethoxydecane N-bis(oxyvinyl)-3-aminopropyltrimethoxydecane, N-bis(oxyvinyl)-3-aminopropyltriethoxydecane, and the like. The mixing ratio of the functional decane-containing compound is preferably 40 parts by weight or less based on 100 parts by weight of the total amount of the polymer. The liquid crystal alignment agent of the present invention is preferably at least one polymer selected from the group consisting of polylysine as described above and its quinone imidized polymer, and other additives optionally blended as needed. It is composed of an organic solvent. The organic solvent which can be used in the liquid crystal alignment agent of the present invention may, for example, be a solvent exemplified as a solvent used in the polyamido acid synthesis reaction. Further, it is also possible to appropriately select a poor solvent which can be used in combination as a synthetic reaction of polylysine. Preferred examples of such an organic solvent are -39-201001029, which can be exemplified by, for example, N-methyl-2-diazolone, 7-butane vinegar, buteneamine, hydrazine, hydrazine-dimethylformamidine. Amine, ν, Ν-dimethylacetamide, 4-hydroxy-4-methyl-2-pentanone, ethylene glycol monomethyl ether, butyl lactate, butyl acetate, methyl methoxypropionate, Ethyl ethoxypropionate, ethylene glycol methyl ether, ethylene glycol ether, ethylene glycol n-propyl ether, ethylene glycol isopropyl ether, ethylene glycol n-butyl ether (butyl cellosolve), ethylene glycol dimethyl ether , ethylene glycol ethyl ether acetate, diglyme, diethylene glycol diethyl ether, diethylene glycol monomethyl ether, diethylene glycol monoethyl ether, diethylene glycol monomethyl ether acetate, diethylene glycol monoethyl ether Acetate, diisobutyl ketone, isoamyl propionate, isoamyl isobutyrate, isoamyl ether, and the like. They may be used singly or in combination of two or more. In the liquid crystal alignment agent of the present invention, the solid content concentration (the ratio of the total weight of the liquid crystal alignment agent other than the organic solvent to the total weight of the liquid crystal alignment agent) is appropriately selected in consideration of viscosity, volatility, etc., preferably 1 to 10 The range of % by weight. That is, the liquid crystal alignment agent of the present invention is applied to the surface of the substrate to remove the organic solvent to form a coating film as a liquid crystal alignment film. When the solid content concentration is less than 1% by weight, the thickness of the coating film is too small. In the case where it is difficult to obtain a good liquid crystal alignment film: on the other hand, when the solid content concentration exceeds 10% by weight, a case where the thickness of the coating film is too thick and it is difficult to obtain a good liquid crystal alignment film is also caused, and a liquid crystal alignment agent appears. The viscosity increases, resulting in poor coating performance. The particularly preferable solid content concentration range differs depending on the method used to apply the liquid crystal alignment agent to the substrate. For example, when the spin coating method is employed, it is particularly preferably in the range of 1.5 to 4.5% by weight. When the printing method is employed, it is particularly preferable to make the solid content concentration in the range of 3 to 9 wt%, so that the viscosity of the solution can be lowered from -40 to 201001029 in the range of 12 to 50 mPa.s. When the ink jet method is employed, it is preferable to set the solid content concentration to a range of 1 to 5 % by weight, so that the solution viscosity can be made to fall within the range of 3 to 15 mPa 's. <Liquid Crystal Display Element> The liquid crystal display element of the present invention has a liquid crystal alignment film formed of the liquid crystal alignment agent of the present invention as described above. The liquid crystal display element of the present invention can be produced, for example, by the following method. (1) The liquid crystal alignment agent of the present invention is applied onto one surface of a substrate provided with a patterned transparent conductive film by, for example, a roll coating method, a spin coating method, a printing method, an inkjet method, or the like, followed by heat coating. The coated surface forms a coating film. Here, as the substrate, for example, glass such as float glass or soda lime glass; polyethylene terephthalate, polybutylene terephthalate, polyether mill, polycarbonate, and alicyclic poly A transparent substrate made of plastic such as olefin. As the transparent conductive film provided on the surface of the substrate, an NESA film made of tin oxide (Sn02) (registered trademark of PPG, USA), an ITO film made of indium oxide-tin oxide (In2〇3 - Sn〇2), or the like can be used. The patterned transparent conductive film can be produced by, for example, forming a desired pattern by photolithography after forming a non-patterned transparent conductive film on a substrate. When a transparent conductive film is formed, light having a desired pattern is used. The cover 'a method of directly forming a pattern-shaped transparent conductive film. When the liquid crystal alignment agent is applied, in order to further improve the adhesion between the surface of the substrate and the resin film, for example, a functional decane compound, a functional titanium compound or the like may be applied in advance. After the application of the liquid crystal alignment agent, preheating (prebaking) is preferably carried out for the purpose of preventing the liquid of the applied alignment agent from sagging. The prebaking temperature is -41 - 201001029, preferably 30 to 200 ° C, more preferably 40 to 150. Hey, Tejia 40~100. (: The prebaking time is preferably from 0.1 to 10 minutes, more preferably from 0.5 to 3 minutes. Then, the firing (post-baking) step is carried out for the purpose of completely removing the solvent, etc. The post-baking temperature is preferably from 80 to 300. °C, more preferably 120 to 250 ° C. The post-coating time is preferably from 1 to 180 minutes, more preferably from 10 to 120 minutes. The liquid crystal alignment agent of the present invention is formed into an alignment film by removing an organic solvent after coating. Coating film, and when the polymer contained in the liquid crystal alignment agent of the present invention is poly-proline or a ruthenium-imided polymer having both a quinone ring structure and a proline structure, it is also possible to form a coating. The film is further subjected to a dehydration ring-closure reaction by further heating to form a further yttrium-imided coating film. The thickness of the coating film formed by the ruthenium is preferably 0.001 to Ιμηη, more preferably 0.005 to 0.5 μm. (2) Two substrates in which the liquid crystal alignment film is formed as described above are prefabricated, and liquid crystal cells are produced by arranging liquid crystal between the two substrates. The production of the liquid crystal cells includes, for example, the following two methods. The first method is a previously known method. First, pass The two substrates are disposed opposite to each other through the gap (cell gap), and the respective liquid crystal alignment films are opposed to each other, and the peripheral portions of the two substrates are bonded together with a sealant, and are filled into the interstitial space surrounded by the surface of the substrate and the sealant. After the liquid crystal, the liquid crystal cell is obtained by closing the injection hole. The second method is a method called OneDF (One Dr〇p Fill) method, on one of the two substrates forming the liquid crystal alignment film. Applying, for example, an ultraviolet curable sealant material to the predetermined portion, and then dropping the liquid crystal on the liquid crystal alignment film surface, bonding the other substrate, and causing the liquid crystal alignment film to face the '42-201001029' and then irradiating the entire surface of the substrate with ultraviolet rays. The liquid crystal cell can be obtained by curing the sealant. The liquid crystal alignment agent of the present invention can form a liquid crystal alignment film excellent in vertical alignment, and thus can be manufactured even when a VA type liquid crystal display element is manufactured by the 〇Df method. There is no advantage of the liquid crystal display element having uneven 〇df. In any case, it is necessary to heat the liquid crystal cell to the liquid crystal used. After the temperature of the isotropic phase, the temperature is slowly cooled to room temperature to remove the flow alignment at the time of injection. Then, the liquid crystal display element of the present invention can be obtained by laminating a polarizing plate on the outer surface of the liquid crystal cell. For the agent, for example, an epoxy resin containing an alumina ball as a curing agent and a separator can be used. Examples of the liquid crystal can be a nematic liquid crystal or a dish-shaped liquid crystal. Among them, a nematic liquid crystal can be used, for example, Schiff base liquid crystal, oxidized azo liquid crystal, biphenyl liquid crystal, phenylcyclohexane liquid crystal, ester liquid crystal, terphenyl liquid crystal, biphenyl cyclohexane liquid crystal, pyrimidine liquid crystal, dioxane a hexacyclic liquid crystal, a bicyclooctane liquid crystal, a cubic liquid crystal, etc. Further, cholesteric liquid crystal such as cholesteryl cholesteryl, cholesteryl phthalate or cholesteryl carbonate may be further added to these liquid crystals or may be commercially available. A chiral agent such as "C-15" or "CB-15" (manufactured by MERCK Co., Ltd.) is used. Further, a ferroelectric liquid crystal such as p-methoxybenzylidene-p-amino-2-methylbutylcinnamate may also be used. Further, as a polarizing plate to be bonded to the outer surface of the liquid crystal, a polarizing film called a "H film" obtained by stretching and dispersing polyvinyl alcohol at the same time as an "H film" may be exemplified by a polarizing film sandwiched between a cellulose acetate protective film. A polarizing plate or a polarizing plate made of a ruthenium film itself. [Examples] Example 1 (Synthesis of a compound represented by the above formula (Α-10)) The compound represented by the above formula (Α-10) (hereinafter referred to as "compound (Α-10)") is synthesized according to the following Scheme 1 synthesis.

合成路線1 (1)化合物(Α - 10a)的合成 向裝有攪拌器、氮氣導入管和溫度計的5L三頸燒瓶 中,加入389g /3-膽甾烷醇、201g琥珀酸酐、15gN,N- -44- 201001029 二甲基胺基吡啶、170 ml三乙胺和2L乙酸乙酯,在90 °C 下進行8小時反應。反應結束後’減壓餾出除去乙酸乙酯’ 加入2L氯仿。有機層依次用稀鹽酸洗滌3次,再用水洗滌 4次後,用硫酸鎂乾燥。濃縮有機層,濾出生成的沉澱, 除去溶劑,即製得223g化合物(A — 10a)的白色粉末。 另外,化合物(A- 10a)的合成,可根據需要重複上述 規模,以確保以下實施例的必需量。 (2) 化合物(A — 10b)的合成 向裝有攪拌器、溫度計和氮氣導入管的5L三頸燒瓶 中,加入223g以上合成的化合物(A — 10a)、108g3,5-二硝 基苯甲醯氯、207g碳酸鉀、1 50g碘化鈉和1 5 00 ml N,N-二甲基甲醯胺,在6 0 °C下進行8小時反應。反應結束後, 加入3 L氯仿,將得到的有機層用水洗滌3次,然後用硫酸 鎂乾燥。濃縮有機層,回收析出的固體,將其用乙醇洗滌, 即製得280g化合物(A — 10b)的淡黃色粉末。 (3) 化合物(A — 10)的合成 向裝有攪拌器、溫度計和氮氣導入管的5L三頸燒瓶 中,加入200g以上合成的化合物(A — 10b)、680g氯化錫二 水合物和2 L乙酸乙酯,在回流下進行4小時反應。反應結 束後,將反應混合物依次用氟化鉀水溶液和水進行洗滌。 將有機層用硫酸鎂乾燥,然後濃縮後,用乙醇再結晶,即 製得58g化合物(A- 10)的淡黃色晶體。 實施例2(上述式(A - 18)表示的化合物的合成) 上述式(A- 18)表示的化合物(以下稱爲“化合物(A — -45- 201001029Synthesis of Route 1 (1) Synthesis of Compound (Α-10a) In a 5 L three-necked flask equipped with a stirrer, a nitrogen introduction tube and a thermometer, 389 g /3-cholestanol, 201 g of succinic anhydride, 15 g of N, N- -44- 201001029 Dimethylaminopyridine, 170 ml of triethylamine and 2 L of ethyl acetate were reacted at 90 ° C for 8 hours. After the completion of the reaction, the ethyl acetate was distilled off under reduced pressure, and 2 L of chloroform was added. The organic layer was washed three times with dilute hydrochloric acid and then four times with water and dried over magnesium sulfate. The organic layer was concentrated, and the resulting precipitate was filtered, and solvent was removed to yield 223 g of Compound (A-10a) as a white powder. Further, the synthesis of the compound (A-10a) can be repeated as needed to ensure the necessary amount of the following examples. (2) Synthesis of Compound (A-10b) In a 5 L three-necked flask equipped with a stirrer, a thermometer and a nitrogen introduction tube, 223 g of the above synthesized compound (A-10a), 108 g of 3,5-dinitrobenzene were added. Toluene chloride, 207 g of potassium carbonate, 150 g of sodium iodide and 1 500 ml of N,N-dimethylformamide were reacted at 60 ° C for 8 hours. After completion of the reaction, 3 L of chloroform was added, and the obtained organic layer was washed three times with water and then dried over magnesium sulfate. The organic layer was concentrated, and the precipitated solid was recovered, which was washed with ethanol to obtain 280 g of a pale yellow powder of compound (A - 10b). (3) Synthesis of Compound (A-10) To a 5 L three-necked flask equipped with a stirrer, a thermometer, and a nitrogen introduction tube, 200 g of the above synthesized compound (A-10b), 680 g of tin chloride dihydrate, and 2 were added. L ethyl acetate was reacted under reflux for 4 hours. After the reaction was completed, the reaction mixture was washed successively with an aqueous potassium fluoride solution and water. The organic layer was dried over magnesium sulfate, and then concentrated, and then recrystallised from ethanol to give pale crystals of the compound (A-10). Example 2 (Synthesis of a compound represented by the above formula (A-18)) A compound represented by the above formula (A-18) (hereinafter referred to as "compound (A - 45-201001029)

H0-C2H4-0HH0-C2H4-0H

合成路線上 (1)化合物(A — 18a)的合成 向裝有滴液漏斗、溫度計和氮氣導入管的1L三頸燒瓶 中’加入117g /3-膽留院醇、3.7gN,N -二甲基胺基啦陡、 4〇0 ml四氫呋喃和55 ml三乙胺,用冰冷卻。在此’將加 入到滴液漏斗中的甲磺醯氯3 1 ml和四氫呋喃1 00 ml組成 的溶液經1小時滴入,肖在室溫下攪拌3小時進行反應。 -46 - 201001029 反應結束後,向反應混合物中加入500ml乙酸乙酯,將所 得的有機層用水進行3次分液洗滌後,用硫酸鎂乾燥。然 後,將有機層濃縮至約300 ml後,將其分散至600 ml乙 醇中,濾取生成的白色沉澱,乾燥,即製得117g化合物(A —1 8 a) 〇 (2) 化合物(A— 1 8b)的合成 將46.7g以上製得的化合物(A—18a)、155g乙二醇和 200 ml 1,4 -二氧六環進行混合,在100 °C下加熱攪拌20小 時進行反應。反應結束後,向反應混合物中加入500ml水 和500ml氯仿,充分攪拌後,分離有機層,依次用500ml 碳酸氫鈉的飽和水溶液洗滌1次,用500 ml水洗滌2次。 將有機層用硫酸鎂脫水,過濾並濃縮後,加入500ml乙醇, 在〇°C下攪拌後’靜置一夜。濾出靜置後生成的白色析出 物後,濃縮濾液,除去溶劑,即製得26.3g化合物(A- 18b) 的粗產物黏性液體。 (3) 化合物(A- 1 8c)的合成 將26.3g以上製得的化合物(A — 1 8b)和14g 3,5-二硝基 苯甲醯氯混合,在300 ml四氫呋喃溶劑中、〇°C下攪拌10 分鐘。經10分鐘向其中滴加8.4ml三乙胺後,在室溫下攪 拌3小時進行反應。反應結束後,濃縮反應液,加入5 0 0 m 1 氯仿後,用3 00 ml水洗滌4次。將有機層用硫酸鎂脫水後, 過瀘、濃縮,回收黏性液體。將該黏性液體通過採用矽柱 的柱層析(沖提溶劑:氯仿)進行精製,即製得20g淡黃色 油狀化合物(A — 18c)。 -47- 201001029 (4)化合物(A — 18)的合成 在氮氣環境下,將20g以上製得的(A — 18c)和78g氯 化錫(II)二水合物進行混合,在3 5 0 ml乙酸乙酯溶劑中、 回流下加熱攪拌4小時。然後加入400 ml 2 mol/L的氟化 鉀水溶液並攪拌,濾出析出的鹽。將有機層用400 ml 2 mol/L的氟化鉀洗滌1次,用400 ml水洗滌3次,再用硫 酸鎂脫水後,過濾、濃縮,得到淡黃色粉末。將該製得的 粉末通過柱層析(沖提溶劑:氯仿/乙醇=95/5(體積比))進 行精製,即製得14g白色粉末的(A- 18)。 實施例3(化合物(A-24)的合成) 上述式(A- 24)表示的化合物(以下稱爲“化合物(A-24)”)按照下述合成路線3合成。 -48- 201001029Synthesis of Compound (A-18a) on the Synthetic Route To a 1 L three-necked flask equipped with a dropping funnel, a thermometer and a nitrogen inlet tube, '117 g /3-cholesterol, 3.7 g of N,N-dimethyl The amino group was steep, 4 〇 0 ml of tetrahydrofuran and 55 ml of triethylamine were cooled with ice. Here, a solution of 3 ml of methanesulfonate chloride and 100 ml of tetrahydrofuran added to the dropping funnel was added dropwise over 1 hour, and the mixture was stirred at room temperature for 3 hours to carry out a reaction. -46 - 201001029 After the reaction was completed, 500 ml of ethyl acetate was added to the reaction mixture, and the obtained organic layer was washed three times with water, and then dried over magnesium sulfate. Then, after concentrating the organic layer to about 300 ml, it was dispersed in 600 ml of ethanol, and the resulting white precipitate was collected by filtration and dried to obtain 117 g of a compound (A-1 8 a) 〇(2) compound (A- Synthesis of 1 8b) 46.7 g of the compound (A-18a) obtained above, 155 g of ethylene glycol and 200 ml of 1,4-dioxane were mixed, and the mixture was stirred under heating at 100 ° C for 20 hours to carry out a reaction. After the completion of the reaction, 500 ml of water and 500 ml of chloroform were added to the reaction mixture, and the mixture was stirred well, and the organic layer was separated, washed twice with 500 ml of aqueous sodium hydrogen carbonate, and twice with 500 ml of water. The organic layer was dried over magnesium sulfate, filtered and concentrated, and then, then, 500 ml of ethanol, and stirred at 〇 ° C, and allowed to stand overnight. After filtering off the white precipitate formed after standing, the filtrate was concentrated to remove the solvent to obtain 26.3 g of the crude product viscous liquid of the compound (A-18b). (3) Synthesis of compound (A-1 8c) A mixture of 26.3 g of the above compound (A-18b) and 14 g of 3,5-dinitrobenzimid chloride is mixed in 300 ml of tetrahydrofuran solvent, 〇° Stir for 10 minutes at C. After 8.4 ml of triethylamine was added dropwise thereto over 10 minutes, the reaction was carried out by stirring at room temperature for 3 hours. After completion of the reaction, the reaction solution was concentrated, and after adding 500 ml of chloroform, it was washed four times with 300 ml of water. The organic layer was dehydrated with magnesium sulfate, dried and concentrated to recover a viscous liquid. This viscous liquid was purified by column chromatography (purification solvent: chloroform) using a column to obtain 20 g of a pale yellow oily compound (A - 18c). -47- 201001029 (4) Synthesis of compound (A-18) Under a nitrogen atmosphere, 20 g of the above obtained (A-18c) and 78 g of tin(II) chloride dihydrate were mixed at 305 ml. The mixture was heated and stirred under reflux for 4 hours in an ethyl acetate solvent. Then, 400 ml of a 2 mol/L potassium fluoride aqueous solution was added and stirred, and the precipitated salt was filtered off. The organic layer was washed once with 400 ml of 2 mol/L potassium fluoride, washed three times with 400 ml of water, dehydrated with magnesium sulfate, filtered and concentrated to give a pale yellow powder. The obtained powder was purified by column chromatography (solvent: chloroform/ethanol = 95/5 (volume ratio)) to obtain 14 g of a white powder (A-18). Example 3 (Synthesis of Compound (A-24)) The compound represented by the above formula (A-24) (hereinafter referred to as "compound (A-24)") was synthesized according to the following Scheme 3. -48- 201001029

(A-lOa)(A-lOa)

coo ch2 ch2 COOHCoo ch2 ch2 COOH

BH3/THFBH3/THF

0 2 2 2 ο Η Η Η Η c\ cl cl cl o0 2 2 2 ο Η Η Η Η c\ cl cl cl o

02N o2n02N o2n

COCICOCI

0 2 2 2 ο Η Η H0 2 2 2 ο Η Η H

(A-24b)(A-24b)

2 N (A24c) o2n2 N (A24c) o2n

合成路線3 (1 )化合物(A — 2 4 b )的合成 向裝有滴液漏斗、氮氣導入管和溫度計的5 0 0 ml三頸 燒瓶中,加入24g化合物(A — 10a)和1 50ml四氫呋喃,冷 卻至_1 8°C。經30分鐘向其中滴加55 ml濃度爲0.9 mol/L 的硼烷-四氫肤喃錯合物/四氫呋喃溶液後,在室溫下進一 -49- 201001029 步反應16小時。反應結束後,將反應混合物用冰冷卻,向 其中緩慢加入30 ml水後,再加入乙酸乙酯,將獲得的有 機層依次用飽和碳酸氫鈉水溶液分液洗滌2次,用水分液 洗條3次後’再將有機層用硫酸鎂乾燥,濃縮、乾燥,即 製得17g化合物(A— 24b)的白色粉末。 (2) ( A _ 24c)的合成 向裝有滴液漏斗、氮氣導入管和溫度計的500ml三頸 燒瓶中,加入15g以上製得的化合物(A-24b)、4.5 ml三 乙胺和1 00 ml四氫呋喃,用冰冷卻。在此,用滴液漏斗經 1小時滴加溶於50 ml四氫呋喃中的7.4g 3,5 -二硝基苯甲 醯氯,再在室溫下反應2小時。反應結束後,向反應混合 物中加入乙酸乙酯,將所得有機層依次用碳酸氫鈉水溶液 分液洗滌2次,用水洗滌3次後,將有機層用硫酸鎂乾燥, 然後濃縮、乾燥後,從乙醇中再結晶,即製得1 0g化合物 (A — 24c)。 (3) 化合物(A _ 24)的合成 向裝有回流管、氮氣導入管和溫度計的1L三頸燒瓶 中,加入l〇g以上製得的(A—24c)、95mg 5重量°/〇把碳粉 末、1 2 0 m 1乙醇、6 0 m 1四氫呋喃和3 · 8 m 1肼一水化物, 在室溫下攪拌1小時後,再在7 0 °C下攪拌1小時進行反應。 反應結束後,將反應混合物用矽藻土過濾,向所得濾液中 加入300 ml乙酸乙酯,將所得有機層用水分液洗滌3次 後,濃縮、乾燥。將該乾燥物從乙醇中再結晶,即製得7g 化合物(A— 24)。 -50- 201001029 實施例4 上述式(A - 22)表示的化合物(以下稱爲“化合物(A - 22)”)按照下述合成路線4合成。Synthesis of Route 3 (1) Synthesis of Compound (A - 2 4 b ) To a 500 ml three-necked flask equipped with a dropping funnel, a nitrogen inlet tube and a thermometer, 24 g of the compound (A-10a) and 150 ml of tetrahydrofuran were added. , cooled to _1 8 ° C. After 55 ml of a borane-tetrahydrofuran complex/tetrahydrofuran solution having a concentration of 0.9 mol/L was added dropwise thereto over 30 minutes, the mixture was reacted at room temperature for -16-201001029 for 16 hours. After the reaction was completed, the reaction mixture was cooled with ice, and 30 ml of water was slowly added thereto, and then ethyl acetate was added thereto, and the obtained organic layer was washed twice with a saturated aqueous solution of sodium hydrogencarbonate, and washed with water. After that, the organic layer was dried over magnesium sulfate, concentrated and dried to give a white powder of 17 g of compound (A-24b). (2) Synthesis of (A _ 24c) In a 500 ml three-necked flask equipped with a dropping funnel, a nitrogen introduction tube and a thermometer, 15 g of the compound (A-24b) obtained above, 4.5 ml of triethylamine and 1 00 were added. Ml tetrahydrofuran, cooled with ice. Here, 7.4 g of 3,5-dinitrobenzhydryl chloride dissolved in 50 ml of tetrahydrofuran was added dropwise with a dropping funnel over 1 hour, and the mixture was further reacted at room temperature for 2 hours. After the completion of the reaction, ethyl acetate was added to the reaction mixture, and the obtained organic layer was washed twice with aqueous sodium hydrogen carbonate solution and then washed three times with water, and then the organic layer was dried over magnesium sulfate, then concentrated and dried Recrystallization in ethanol gave 10 g of the compound (A-24c). (3) Synthesis of compound (A _ 24) In a 1 L three-necked flask equipped with a reflux tube, a nitrogen introduction tube, and a thermometer, (A-24c), 95 mg, 5 wt%/〇 Carbon powder, 120 mmol of ethanol, 60 mmol of tetrahydrofuran, and 3·8 m of monohydrate monohydrate were stirred at room temperature for 1 hour, and then stirred at 70 ° C for 1 hour to carry out a reaction. After the completion of the reaction, the reaction mixture was filtered through Celite, and ethyl acetate (300 ml) was added to the obtained filtrate, and the obtained organic layer was washed three times with water, then concentrated and dried. The dried product was recrystallized from ethanol to obtain 7 g of a compound (A-24). -50-201001029 Example 4 The compound represented by the above formula (A-22) (hereinafter referred to as "compound (A-22)") was synthesized according to the following Synthesis Scheme 4.

Pd(PPh3)4Pd(PPh3)4

00H2H28 C—CICIC00H2H28 C-CICIC

h2nH2n

(A-22) NH, 合成路線4 (1)化合物(A— 22b)的合成 將47g化合物(A — 10a)和28g3,5-(N,N-二烯丙基)二胺 基苯酚混合,在400 ml四氫呋喃中、0°C下攪拌。向其中 -51 - 201001029 加入25gN,N-二環己基碳化二亞胺和2.4gN,N-二甲基胺基 吡啶後,在2 5 °C下攪拌4小時。然後加入氯仿,將有機層 進行水洗後,濃縮。將濃縮物通過柱層析(沖提溶劑:己院: 乙酸乙酯=8:1(體積比))進行精製,即製得化合物(A - 22b> 的粗精製物。 (2)化合物(A— 22)的合成 將38g以上製得的(八一2213)、2381,3-二甲基巴比妥酸 和l.lg四(三苯基膦)紀混合,在200 ml二氯甲院中、35 °C下攪拌7小時進行反應。反應結束後,將反應混合物依 次用飽和碳酸氫鈉水溶液和水洗滌後,濃縮有機層,除去 溶劑,得到褐色的黏性液體。將該黏性液體通過柱層析(沖 提溶劑:氯仿:乙醇=95:5(體積比))進行精製後,再從乙醇 中進行再結晶,即製得13g化合物(A- 22)的淡黃色粉末。 實施例5 上述式(A- 26)表示的化合物(以下稱爲“化合物(A-2 6)”)按照下述合成路線5合成。 -52- 201001029(A-22) NH, Synthesis Scheme 4 (1) Synthesis of Compound (A-22b) 47 g of the compound (A-10a) and 28 g of 3,5-(N,N-diallyl)diaminophenol were mixed. Stir in 400 ml of tetrahydrofuran at 0 °C. After adding 25 g of N,N-dicyclohexylcarbodiimide and 2.4 g of N,N-dimethylaminopyridine to -51 - 201001029, the mixture was stirred at 25 ° C for 4 hours. Then, chloroform was added, and the organic layer was washed with water and then concentrated. The concentrate was purified by column chromatography (solvent: hexane: ethyl acetate = 8:1 (volume ratio)) to obtain a crude product of the compound (A - 22b > (2) Compound (A) - 22) Synthesis of 38g of the above (August 2213), 2381,3-dimethylbarbituric acid and l.lg tetrakis(triphenylphosphine) are mixed in 200 ml of dichlorocarbyl The reaction was carried out by stirring at 35 ° C for 7 hours. After the reaction was completed, the reaction mixture was washed successively with a saturated aqueous sodium hydrogen carbonate solution and water, and then the organic layer was concentrated to remove the solvent to give a brown viscous liquid. Column chromatography (purification solvent: chloroform: ethanol = 95:5 (volume ratio)) was purified, and then recrystallized from ethanol to obtain 13 g of a pale yellow powder of the compound (A-22). The compound represented by the above formula (A-26) (hereinafter referred to as "compound (A-2 6)") is synthesized according to the following Synthesis Scheme 5. -52 - 201001029

COO \ CH2COO \ CH2

ch2 I z ch2 f ^ COOH (A — 26a)Ch2 I z ch2 f ^ COOH (A — 26a)

SnCI2 合成路線5 (1 )化合物(A — 26a)的合成 向裝有攪拌器、氮氣導入管和溫度計的10L三頸燒瓶 中,加入778g/3-膽留烷醇、458g戊二酐、30g N,N -二甲 基胺基吡啶、340 ml三乙胺和4L乙酸乙酯,在90 °C下反 -53- 201001029 應8小時。反應結束後,減壓餾出除去乙酸乙酯,加入2L 氯仿。將有機層依次用稀鹽酸洗滌3次,再用水洗滌4次 後,用硫酸鎂乾燥。濃縮有機層,濾出生成的沉澱,除去 溶劑,即製得49 8g化合物(A- 26a)的白色粉末。 (2) 化合物(A— 26b)的合成 向裝有攪拌器、溫度計和氮氣導入管的5L三頸燒瓶 中,加入254g以上合成的化合物(A— 26a)、108g3,5 -二硝 基苯甲醯氯、207g碳酸鉀、150g碘化鈉和1500 ml N,N-二甲基甲醯胺,在6 0 °C下進行8小時反應。反應結束後, 加入3 L氯仿,將得到的有機層用水洗滌3次,然後用硫酸 鎂乾燥。濃縮有機層,回收析出的固體,將其用乙醇洗滌, 即製得305g化合物(A— 26b)的淡黃色粉末。 (3) 化合物(A— 26)的合成 向裝有攪拌器、溫度計和氮氣導入管的5L三頸燒瓶 中’加入228g以上合成的化合物(A— 26b)、680g氯化錫二 水合物和2L乙酸乙酯,在回流下進行4小時反應。反應結 束後,將反應混合物依次用氟化鉀水溶液和水進行洗滌。 將有機層用硫酸鎂乾燥,然後濃縮後,用乙醇再結晶,即 製得60g化合物(A- 26)的淡黃色晶體。 實施例6(醯亞胺化聚合物的合成例1) 將作爲四羧酸二酐的2,3,5 -三羧基環戊基醋酸二酐 6 5g(TCA),作爲二胺化合物的對苯二胺31g和上述實施例 1中合成的化合物(A — 10)9.2g(相對於1莫耳當量TCA,相 當於0.05莫耳當量)溶於420g N -甲基-2-吡咯烷酮中,在 -54- 201001029 6〇°C下反應6小時,得到含20重量%聚醯胺酸的溶液。該 聚醯胺酸溶液的溶液黏度爲4700 mPa_s。 然後,向所得聚醯胺酸溶液中追加980g N-甲基-2-吡 咯烷酮,再加入23g吡啶和30g醋酸酐,在110°C下進行4 小時脫水閉環反應。脫水閉環反應後,通過將體系內的溶 劑用新的N-甲基-2-吡咯烷酮進行溶劑置換(在此操作中將 脫水閉環反應中使用的吡啶和醋酸酐除去至體系外。下 同),得到含有20重量%醯亞胺化率約爲49%的醯亞胺化聚 合物(PI—1)的溶液。取少量溶液,用N-甲基-2-吡咯烷酮 稀釋成聚合物濃度爲6.0重量%的溶液,測定的溶液黏度爲 2 2 m P a s。 實施例7(醯亞胺化聚合物的合成例2) 將作爲四羧酸二酐的 2,3,5-三羧基環戊基醋酸二酐 60g(TCA),作爲二胺化合物的對苯二胺27g和上述實施例 1中合成的化合物(A — 10)17g(相對於1莫耳當量TCA,相 當於0.1莫耳當量)溶於420gN-甲基-2-吡咯烷酮中,在60 °C下反應6小時,得到含20重量%聚醯胺酸的溶液。該聚 醯胺酸溶液的溶液黏度爲3700 mPa_s。 然後,向所得聚醯胺酸溶液中追加980g N-甲基-2-吡 咯烷酮,再加入21g耻啶和28g醋酸酐,在110°C下進行4 小時脫水閉環反應。脫水閉環反應後,通過將體系內的溶 劑用新的N-甲基-2-吡咯烷酮進行溶劑置換,得到含有20 重量%醯亞胺化率約爲50%的醯亞胺化聚合物(PI — 2)的溶 液。取少量該溶液,用N-甲基-2-吡咯烷酮稀釋成聚合物濃 -55- 201001029 度爲6.0重量%的溶液,測定的溶液黏度爲20 mPa,s。 實施例8 (醯亞胺化聚合物的合成例3 ) 將作爲四羧酸二酐的 2,3,5 -三羧基環戊基醋酸二酐 2 1g(TCA)以及作爲二胺化合物的對苯二胺9.0g和上述實施 例2中合成的化合物(A_18)5.3g(相對於1莫耳當量TCA, 相當於0.1莫耳當量)溶於140g N-甲基-2-吡咯烷酮中,在 6 0 °C下反應6小時,得到含2 0重量%聚醯胺酸的溶液。該 聚醯胺酸溶液的溶液黏度爲3500 mPai» 然後,向所得聚醯胺酸溶液中追加3 25 g N-甲基-2-吡 咯烷酮,再加入15g吡啶和19g醋酸酐,在110°C下進行4 小時脫水閉環反應。脫水閉環反應後,通過將體系內的溶 劑用新的N-甲基-2-吡咯烷酮進行溶劑置換,得到含有20 重量%醯亞胺化率約爲78 %的醯亞胺化聚合物(PI- 3)的溶 液。取少量該溶液,用N-甲基-2-吡咯烷酮稀釋成聚合物濃 度爲6.0重量%的溶液,測定的溶液黏度爲21 mPa‘s。 實施例9(醯亞胺化聚合物的合成例4) 將作爲四羧酸二酐的 2,3,5-三羧基環戊基醋酸二酐 20g(TCA)以及作爲二胺化合物的對苯二胺8.9g和上述實施 例3中合成的化合物(A-24)5.6g(相對於1莫耳當量TCA, 相當於0.1莫耳當量)溶於140g N-甲基-2-吡咯烷酮中,在 6 0 °C下反應6小時,得到含2 0重量%聚醯胺酸的溶液。該 聚醯胺酸溶液的溶液黏度爲3600 mPa_s。 然後,向所得聚醯胺酸溶液中追加3 2 5 g N-甲基-2-吡 咯烷酮,再加入14g吡啶和19g醋酸酐,在ll〇°C下進行4 -56- 201001029 小時脫水閉環反應。脫水閉環反應後,通過將體系內的溶 劑用新的N-甲基-2-肶咯烷酮進行溶劑置換,得到含有20 重量%醯亞胺化率約爲80%的醯亞胺化聚合物(PI - 4)的溶 液。取少量該溶液,用N -甲基-2 -吡咯烷酮稀釋成聚合物濃 度爲6.0重量%的溶液,測定的溶液黏度爲22 mPa‘s。 實施例10(醯亞胺化聚合物的合成例5) 將作爲四羧酸二酐的2,3, 5·三羧基環戊基醋酸二酐 2 0g(TCA)以及作爲二胺化合物的對苯二胺8.9g和上述實施 例4中合成的化合物(A-22)5.5g(相對於1莫耳當量TCA’ 相當於〇_1莫耳當量)溶於140g N-甲基-2-吡咯烷酮中,在 6 0 °C下反應6小時,得到含2 0重量%聚醯胺酸的溶液。該 聚醯胺酸溶液的溶液黏度爲3 700 mPa.s。 然後’向所得聚醯胺酸溶液中追加325g N-甲基-2-吡 咯烷酮’再加入1 4 g吡啶和1 9 g醋酸酐,在1 1 0 °C下進行4 小時脫水閉環反應。脫水閉環反應後,通過將體系內的溶 劑用新的N-甲基-2-吡咯烷酮進行溶劑置換,得到含有20 重量%醯亞胺化率約爲7 9 %的醯亞胺化聚合物(P I - 5 )的溶 液。取少量該溶液,用N-甲基-2-吡咯烷酮稀釋成聚合物濃 度爲6.0重量%的溶液,測定的溶液黏度爲22 mPa.s。 實施例1 1(醯亞胺化聚合物的合成例6) 將作爲四羧酸二酐的2,3,5 -三羧基環戊基醋酸二酐 20g(TCA)以及作爲二胺化合物的對苯二胺89g和上述實施 例5中合成的化合物(A-26)5_8g(相對於1莫耳當量TCA, 相當於0.1莫耳當量)溶於14〇g N-甲基-2-吡咯烷酮中,在 -57- 201001029 6 0 °C下反應6小時,得到含2 0重量%聚醯胺酸的溶液。該 聚醯胺酸溶液的溶液黏度爲3 400 mP a· s。 然後,向所得聚醯胺酸溶液中追加3 2 5 g N-甲基-2-11比 咯烷酮,再加入14g吡啶和19g醋酸酐,在1 l〇°C下進行4 小時脫水閉環反應。脫水閉環反應後,通過將體系內的溶 劑用新的N-甲基-2-吡咯烷酮進行溶劑置換,得到含有20 重量%醯亞胺化率約爲78%的醯亞胺化聚合物(PI - 6)的溶 液。取少量該溶液,用N-甲基-2-吡咯烷酮稀釋成聚合物濃 度爲6.0重量%的溶液,測定的溶液黏度爲21 mPa‘s。 實施例12(醯亞胺化聚合物的合成例7) 將作爲四羧酸二酐的 2,3,5-三羧基環戊基醋酸二酐 65g(TCA)以及作爲二胺化合物的對苯二胺31g和上述實施 例1中合成的化合物(A — 10)9.2g(相對於1莫耳當量TCA, 相當於0.05莫耳當量)溶於420gN -甲基-2-吡咯烷酮中,在 6 0 °C下反應6小時,得到含2 0重量%聚醯胺酸的溶液。該 聚醯胺酸溶液的溶液黏度爲4700mPa*s。 然後,向所得聚醯胺酸溶液中追加980g N -甲基- 2-¾ 咯烷酮,再加入46g吡啶和60g醋酸酐,在1 1〇。<:下進行4 小時脫水閉環反應。脫水閉環反應後,通過將體系內的溶 劑用新的N-甲基-2-吡咯烷酮進行溶劑置換,得到含有2〇 重量%醯亞胺化率約爲7 8 %的醯亞胺化聚合物(p ! — 7)的溶 液。取少量該溶液’用N-甲基-2-吡咯烷酮稀釋成聚合物濃 度爲6.0重量%的溶液,測定的溶液黏度爲22 mpa.s。 實施例13(醯亞胺化聚合物的合成例8) -58- 201001029 將作爲四羧酸二酐的2,3,5_三羧基環戊基醋酸二酐 60g(TCA)以及作爲二胺化合物的對苯二胺27g和上述實施 例1中合成的化合物(A — l〇)l7g(相對於1莫耳當量TCA, 相當於0.1莫耳當量)溶於42〇g N-甲基-2-吡咯烷酮中,在 6 0 °C下反應6小時,得到含2 0重量%聚醯胺酸的溶液。該 聚醯胺酸溶液的溶液黏度爲3700 mPa.s。 然後’向所得聚醯胺酸溶液中追加9 8 0g N-甲基-2-吡 咯烷酮,再加入42g吡啶和56g醋酸酐,在11〇。(:下進行4 小時脫水閉環反應。脫水閉環反應後,通過將體系內的溶 劑用新的N-甲基-2-吡咯烷酮進行溶劑置換,得到含有20 重量%醯亞胺化率約爲8 0 %的醯亞胺化聚合物(P I - 8)的溶 液。取少量該溶液,用N-甲基-2-吡咯烷酮稀釋成聚合物濃 度爲6.0重量%的溶液,測定的溶液黏度爲20 mPa.s。 比較合成例1 (醯亞胺化聚合物的比較合成例) 將作爲四羧酸二酐的2,3,5 -三羧基環戊基醋酸二酐 29g(TCA)、作爲二胺化合物的對苯二胺llg和下述式(R-1)Synthesis of SnCI2 Synthetic Route 5 (1) Compound (A-26a) In a 10 L three-necked flask equipped with a stirrer, a nitrogen inlet tube and a thermometer, 778 g/3-cholalkanol, 458 g of glutaric anhydride, 30 g of N were added. , N-dimethylaminopyridine, 340 ml of triethylamine and 4 L of ethyl acetate, at -90-201001029 at 90 ° C should be 8 hours. After completion of the reaction, ethyl acetate was distilled off under reduced pressure, and 2 L of chloroform was added. The organic layer was washed three times with dilute hydrochloric acid and then four times with water and dried over magnesium sulfate. The organic layer was concentrated, and the resulting precipitate was filtered, and solvent was removed to give a white powder of 49 g of compound (A-26a). (2) Synthesis of Compound (A-26b) To a 5 L three-necked flask equipped with a stirrer, a thermometer and a nitrogen introduction tube, 254 g of the above synthesized compound (A-26a), 108 g of 3,5-dinitrobenzene were added. Toluene chloride, 207 g of potassium carbonate, 150 g of sodium iodide and 1500 ml of N,N-dimethylformamide were reacted at 60 ° C for 8 hours. After completion of the reaction, 3 L of chloroform was added, and the obtained organic layer was washed three times with water and then dried over magnesium sulfate. The organic layer was concentrated, and the precipitated solid was recovered, which was washed with ethanol to obtain 305 g of a pale yellow powder of compound (A-26b). (3) Synthesis of Compound (A-26) To a 5 L three-necked flask equipped with a stirrer, a thermometer, and a nitrogen introduction tube, '228 g of the above synthesized compound (A-26b), 680 g of tin chloride dihydrate, and 2 L were added. Ethyl acetate was reacted under reflux for 4 hours. After the reaction was completed, the reaction mixture was washed successively with an aqueous potassium fluoride solution and water. The organic layer was dried over magnesium sulfate, and then concentrated, and then recrystallised from ethanol to give 60 g of compound (A-26) as pale yellow crystals. Example 6 (Synthesis Example 1 of a ruthenium iodide polymer) 6 5 g (TCA) of 2,3,5-tricarboxycyclopentylacetic acid dianhydride as a tetracarboxylic dianhydride, and p-benzene as a diamine compound 31 g of diamine and 9.2 g of the compound (A-10) synthesized in the above Example 1 (relative to 1 molar equivalent of TCA, equivalent to 0.05 molar equivalent) were dissolved in 420 g of N-methyl-2-pyrrolidone, at - 54-201001029 Reaction at 6 ° C for 6 hours gave a solution containing 20% by weight of polyglycine. The solution viscosity of the polyaminic acid solution was 4,700 mPa_s. Then, 980 g of N-methyl-2-pyrrolidone was added to the obtained polyamic acid solution, and 23 g of pyridine and 30 g of acetic anhydride were further added, and a dehydration ring-closure reaction was carried out at 110 ° C for 4 hours. After the dehydration ring closure reaction, the solvent in the system is replaced with a new N-methyl-2-pyrrolidone (in this operation, the pyridine and acetic anhydride used in the dehydration ring-closure reaction are removed to the outside of the system. The same applies hereinafter). A solution containing 20% by weight of a ruthenium iodide polymer (PI-1) having a ruthenium iodide ratio of about 49% was obtained. A small amount of the solution was taken and diluted with N-methyl-2-pyrrolidone to a solution having a polymer concentration of 6.0% by weight, and the solution viscosity was determined to be 2 2 m P a s. Example 7 (Synthesis Example 2 of a ruthenium iodide polymer) 60 g (TCA) of 2,3,5-tricarboxycyclopentylacetic acid dianhydride as a tetracarboxylic dianhydride as a diamine compound 27 g of the amine and 17 g of the compound (A-10) synthesized in the above Example 1 (corresponding to 1 molar equivalent of TCA, equivalent to 0.1 molar equivalent) were dissolved in 420 g of N-methyl-2-pyrrolidone at 60 ° C. The reaction was carried out for 6 hours to obtain a solution containing 20% by weight of polyamic acid. The solution viscosity of the polyaminic acid solution was 3700 mPa_s. Then, 980 g of N-methyl-2-pyrrolidone was added to the obtained polyaminic acid solution, and 21 g of dioxin and 28 g of acetic anhydride were further added, and a dehydration ring-closure reaction was carried out at 110 ° C for 4 hours. After the dehydration ring closure reaction, the solvent in the system was replaced with a new N-methyl-2-pyrrolidone to obtain a ruthenium iodide polymer (PI-containing 20% by weight of ruthenium iodide ratio of about 50%). 2) solution. A small amount of this solution was taken and diluted with N-methyl-2-pyrrolidone to give a solution having a concentration of -55 to 201001029 to 6.0% by weight, and the solution viscosity was determined to be 20 mPa, s. Example 8 (Synthesis Example 3 of a ruthenium iodide polymer) 2,3 g (TCA) of 2,3,5-tricarboxycyclopentylacetic acid dianhydride as a tetracarboxylic dianhydride, and p-benzene as a diamine compound 9.0 g of diamine and 5.3 g of compound (A-18) synthesized in the above Example 2 (relative to 1 molar equivalent of TCA, equivalent to 0.1 molar equivalent) were dissolved in 140 g of N-methyl-2-pyrrolidone at 60 The reaction was carried out at ° C for 6 hours to obtain a solution containing 20% by weight of polyamic acid. The solution viscosity of the polyaminic acid solution is 3500 mPai» Then, 3 25 g of N-methyl-2-pyrrolidone is added to the obtained polyamic acid solution, and 15 g of pyridine and 19 g of acetic anhydride are further added at 110 ° C. A 4 hour dehydration ring closure reaction was carried out. After the dehydration ring closure reaction, the solvent in the system was replaced with a new N-methyl-2-pyrrolidone to obtain a ruthenium iodide polymer (PI-) containing 20% by weight of a ruthenium iodide ratio of about 78%. 3) solution. A small amount of this solution was taken and diluted with N-methyl-2-pyrrolidone to a solution having a polymer concentration of 6.0% by weight, and the solution viscosity was measured to be 21 mPa's. Example 9 (Synthesis Example 4 of a ruthenium iodide polymer) 2,3,5-tricarboxycyclopentylacetic acid dianhydride 20 g (TCA) as a tetracarboxylic dianhydride and p-phenylene as a diamine compound 8.9 g of the amine and 5.6 g of the compound (A-24) synthesized in the above Example 3 (relative to 1 molar equivalent of TCA, equivalent to 0.1 molar equivalent) were dissolved in 140 g of N-methyl-2-pyrrolidone at 6 The reaction was carried out at 0 ° C for 6 hours to obtain a solution containing 20% by weight of polyamic acid. The solution viscosity of the polyaminic acid solution was 3600 mPa_s. Then, 3 2 5 g of N-methyl-2-pyrrolidone was added to the obtained polyamic acid solution, and 14 g of pyridine and 19 g of acetic anhydride were further added, and a dehydration ring-closure reaction was carried out at 4 °C to 201001029 hours at ll °C. After the dehydration ring closure reaction, the solvent in the system was replaced with a new N-methyl-2-pyrrolidone to obtain a ruthenium imidized polymer containing 20% by weight of a ruthenium iodide ratio of about 80%. (PI-4) solution. A small amount of this solution was taken and diluted with N-methyl-2-pyrrolidone to a solution having a polymer concentration of 6.0% by weight, and the solution viscosity was determined to be 22 mPa's. Example 10 (Synthesis Example 5 of a ruthenium iodide polymer) 2,3,5·tricarboxycyclopentylacetic acid dianhydride 20 g (TCA) as a tetracarboxylic dianhydride, and p-benzene as a diamine compound 8.9 g of diamine and 5.5 g of the compound (A-22) synthesized in the above Example 4 (corresponding to 1 molar equivalent of TCA' equivalent to 〇_1 molar equivalent) were dissolved in 140 g of N-methyl-2-pyrrolidone The reaction was carried out at 60 ° C for 6 hours to obtain a solution containing 20% by weight of polyamic acid. The solution of the polyaminic acid solution has a viscosity of 3 700 mPa·s. Then, 325 g of N-methyl-2-pyrrolidone was added to the obtained polyamic acid solution, and then 14 g of pyridine and 19 g of acetic anhydride were added, and a dehydration ring-closure reaction was carried out at 110 ° C for 4 hours. After the dehydration ring closure reaction, the solvent in the system was replaced with a new N-methyl-2-pyrrolidone to obtain a ruthenium iodide polymer (PI) containing 20% by weight of ruthenium iodide ratio of about 79%. - 5) solution. A small amount of this solution was taken and diluted with N-methyl-2-pyrrolidone to a solution having a polymer concentration of 6.0% by weight, and the solution viscosity was determined to be 22 mPa·s. Example 1 1 (Synthesis Example 6 of a ruthenium iodide polymer) 2,3,5-tricarboxycyclopentyl acetic acid dianhydride 20 g (TCA) as a tetracarboxylic dianhydride, and p-benzene as a diamine compound 89 g of diamine and 5-8 g of the compound (A-26) synthesized in the above Example 5 (relative to 1 mol equivalent of TCA, equivalent to 0.1 mol equivalent) are dissolved in 14 g of N-methyl-2-pyrrolidone. -57-201001029 6 hours at 0 ° C to obtain a solution containing 20% by weight of poly-proline. The solution viscosity of the polyamic acid solution was 3 400 mP a·s. Then, 3 25 g of N-methyl-2-11 pyrrolidone was added to the obtained polyamic acid solution, and 14 g of pyridine and 19 g of acetic anhydride were further added, and dehydration ring closure reaction was carried out at 1 l ° C for 4 hours. . After the dehydration ring closure reaction, the solvent in the system was replaced with a new N-methyl-2-pyrrolidone to obtain a ruthenium iodide polymer (PI-containing 20% by weight of ruthenium iodide ratio of about 78%). 6) solution. A small amount of this solution was taken and diluted with N-methyl-2-pyrrolidone to a solution having a polymer concentration of 6.0% by weight, and the solution viscosity was measured to be 21 mPa's. Example 12 (Synthesis Example 7 of a ruthenium iodide polymer) 65 g (TCA) of 2,3,5-tricarboxycyclopentylacetic acid dianhydride as a tetracarboxylic dianhydride, and p-phenylene as a diamine compound Amine 31 g and 9.2 g of the compound (A-10) synthesized in the above Example 1 (relative to 1 molar equivalent of TCA, equivalent to 0.05 molar equivalent) were dissolved in 420 g of N-methyl-2-pyrrolidone at 60 ° The reaction was carried out for 6 hours at C to obtain a solution containing 20% by weight of polyamic acid. The solution viscosity of the polyaminic acid solution was 4700 mPa*s. Then, 980 g of N-methyl-2-3⁄4-rrolidone was added to the obtained polyamic acid solution, and 46 g of pyridine and 60 g of acetic anhydride were further added thereto at 1 1 Torr. <: A 4 hour dehydration ring closure reaction was carried out. After the dehydration ring closure reaction, the solvent in the system is subjected to solvent replacement with a new N-methyl-2-pyrrolidone to obtain a ruthenium iodide polymer containing 2% by weight of ruthenium iodide ratio of about 78% ( p ! — 7) solution. A small amount of this solution was diluted with N-methyl-2-pyrrolidone to a solution having a polymer concentration of 6.0% by weight, and the solution viscosity was determined to be 22 mpa.s. Example 13 (Synthesis Example 8 of ruthenium iodide polymer) -58- 201001029 2,3,5-tricarboxycyclopentylacetic acid dianhydride 60 g (TCA) as tetracarboxylic dianhydride and as a diamine compound 27 g of p-phenylenediamine and 7 g of the compound (A-1) synthesized in the above Example 1 (relative to 1 mol equivalent of TCA, equivalent to 0.1 mol equivalent) were dissolved in 42 g of N-methyl-2- The pyrrolidone was reacted at 60 ° C for 6 hours to obtain a solution containing 20% by weight of polyglycine. The solution viscosity of the polyaminic acid solution was 3700 mPa.s. Then, 980 g of N-methyl-2-pyrrolidone was added to the obtained polyamic acid solution, and 42 g of pyridine and 56 g of acetic anhydride were further added thereto at 11 Torr. (: 4 hours of dehydration ring closure reaction. After the dehydration ring closure reaction, the solvent in the system was replaced with a new N-methyl-2-pyrrolidone solvent to obtain a 20% by weight hydrazine imidization rate of about 80 A solution of % ruthenium iodide polymer (PI-8). A small amount of this solution was diluted with N-methyl-2-pyrrolidone to a solution having a polymer concentration of 6.0% by weight, and the solution viscosity was determined to be 20 mPa. s. Comparative Synthesis Example 1 (Comparative Synthesis Example of Europium Amidated Polymer) 29 g (TCA) of 2,3,5-tricarboxycyclopentylacetic acid dianhydride as a tetracarboxylic dianhydride, as a diamine compound P-phenylenediamine 11g and the following formula (R-1)

表示的化合物9.9 g(相對於1莫耳當量TCA,相當於〇.2莫 耳當量)溶於450gN -甲基-2-吡咯烷酮中,在60°C下反應6 小時,得到含20重量%聚醯胺酸的溶液。該聚醯胺酸溶液 的溶液黏度爲3 500 mPa_s。 -59- 201001029 然後,向所得聚醯胺酸溶液中追加5 00g N-甲基-2-吡 咯烷酮,再加入l〇g吡啶和13g醋酸酐,在ll〇°C下進行4 小時脫水閉環反應。脫水閉環反應後’通過將體系內的溶 劑用新的N-甲基-2-吡咯烷酮進行溶劑置換’得到含有20 重量%醯亞胺化率約爲49%的醯亞胺化聚合物(B-1)的溶 液。取少量該溶液,用N-甲基-2-吡咯烷酮稀釋成聚合物濃 度爲6.0重量%的溶液,測定的溶液黏度爲19 mPai。 實施例1 4 (液晶配向劑的配製和評價) <液晶配向劑的配製> (1) 印刷性評價用液晶配向劑的配製 向上述實施例6中製得的含醯亞胺化聚合物(PI - 1)的 溶液中加入N-甲基-2-吡咯烷酮(NMP)和丁基溶纖劑(BC), 配成溶劑組成爲NMP : BC = 50 : 50(重量比)、固體含量濃 度爲6.0重量%的溶液。將該溶液用孔徑爲1 μιη的濾器過 濾,配製得印刷性評價用的液晶配向劑。 (2) 製造液晶顯示元件用的液晶配向劑的配製 向上述實施例6中製得的含醯亞胺化聚合物(ΡΙ - 1)的 溶液中加入Ν -甲基-2-耻咯烷酮(ΝΜΡ)和丁基溶纖劑(BC), 配成溶劑組成爲NMP : BC = 5 0 : 5 0(重量比)、固體含量濃 度爲4重量%的溶液。將該溶液用孔徑爲〗μιη的濾器過濾, 配製得製造液晶顯示元件用的液晶配向劑。 <液晶配向劑的評價> 採用這些液晶配向劑中的任何一者,按照以下的方法 進行評價。評價結果列於表1。 -60- 201001029 (1) 印刷性的評價 對於上述配製的印刷性評價用液晶配向劑,採用液晶 配向膜印刷機(日本寫真印刷(股)製造),在下述條件下塗敷 於帶有ιτο膜製透明電極的玻璃基板的透明電極面上,在 80°C下加熱1分鐘(預烘焙)除去溶劑後,再在2〇(TC下加熱 60分鐘(後烘焙),形成膜厚爲60 nm的塗膜。對該塗膜進 行目測觀察,調查有無褶皺和塗敷不均,當印刷不均和針 孔均沒有觀察到時,印刷性評價爲“良好”。 (2) 垂直配向控制力的評價 採用旋塗機將上述配製的製造液晶顯示元件用的液晶 配向劑塗敷在厚度爲1mm的玻璃基板的一面上設置的IT 0 膜製透明導電膜上,在80°C下加熱1分鐘(預烘焙)除去溶 劑後,再在200 °C下加熱60分鐘,形成膜厚爲0.08 μπι的 塗膜。然後,採用裝有纏繞人造纖維布的輥的打磨機,在 輥轉速爲400 rpm、操作臺移動速度爲3cm/秒,絨毛擠入 長度爲0.4mm的條件下,對該塗膜進行打磨處理。然後, 在超純水中用超音波洗滌10分鐘後,接著在100 °C的潔淨 烘箱中乾燥10分鐘,製得具有進行了打磨處理的液晶配向 膜的基板。重複進行該操作,製作一對(2塊)具有進行了打 磨處理的液晶配向膜的基板。 然後,在上述一對基板的具有液晶配向膜的各外緣 上,塗敷加入了直徑爲5.5μιη的氧化鋁球的環氧樹脂黏合 劑後,使液晶配向膜面逆平行地重合並壓合,再使黏合劑 固化。接著,通過液晶注入口向一對基板間塡充向列型液 -61 - 201001029 晶(MERCK社製,MLC-660 8)後,用丙烯酸類光固化黏合劑 將液晶注入口封閉,製造出垂直配向控制力評價用的液晶 胞。 對該液晶顯示元件,採用結晶旋轉角法測定的預傾角 爲86°以上的情況,垂直配向控制力評價爲“良好”,不到 86°的情況,垂直配向控制力評價爲“不良”。 另外,已知上述進行的打磨處理,對液晶配向膜的垂 直配向控制力具有消減效果。故而當即使進行打磨處理也 顯示8 6°以上預傾角的情形,垂直配向控制力可以說極其優 良,能夠獲得這種結果的液晶配向劑,即使將其用於通過 ODF方式製造VA型液晶顯示元件時,根據經驗也可以知 道不會產生顯示不勻。 (3) 電壓保持率的評價 除了不進行打磨處理以外,與上述(2)垂直配向控制力 的評價中同樣地製造液晶胞。 在60°C下,在16.7毫秒的時間跨度內,對該液晶胞施 加5V的電壓,電壓施加時間爲60微秒,然後測定從電壓 解除至16·7毫秒後的電壓保持率。 (4) 耐熱性的評價(長期連續驅動耐受性的替代評價) 對與上述同樣地製造的液晶胞,首先,在167毫秒的 時間跨度下施加5 V的電壓,電壓施加時間爲6 0微秒,然 後測定從電壓解除至167毫秒後的電壓保持率。此時的數 値作爲初期電壓保持率(VHRBF)。 測定VHRBF後,將液晶顯示元件置於100 °C的烘箱中, -62- 201001029 施加1 0 0 0小時的熱應力。然後將液晶顯示元件在室 置冷卻至室溫後,在與上述初期電壓保持率的測定 條件下,測定施加熱應力後的電壓保持率(VHRaf)。 由下述公式(2)求出熱應力施加前後的電壓保 變化率(△ VHR), Δ VHR(%)= ((VHRbf -VHRaf)-VHRbf)x 1 00 該變化率不足5%的情況,耐熱性評價爲“良好 5%以上的情況,耐熱性評價爲“不良”。 評價結果列於表1。 實施例1 5〜2 3、比較例1 除了液晶配向劑的組成分別如表1中所示以外 述實施例1 4同樣地分別配製2種液晶配向劑,並 價。另外,實施例15和I7〜23中,在向聚合物溶 入規定的溶劑後,相對於100重量份聚合物進一步 20重量份下述式(E-1)表示的環氧基化合物。 溫下靜 相同的 持率的 (2) ”,爲 ,與上 進行評 液中加 加入了The compound represented by 9.9 g (relative to 1 molar equivalent of TCA, equivalent to 0.2 mole equivalent) was dissolved in 450 g of N-methyl-2-pyrrolidone and reacted at 60 ° C for 6 hours to obtain 20% by weight of poly A solution of proline. The solution of the polyaminic acid solution has a viscosity of 3 500 mPa_s. -59-201001029 Then, 500 g of N-methyl-2-pyrrolidone was added to the obtained polyamic acid solution, and 1 g of pyridine and 13 g of acetic anhydride were further added, and a dehydration ring-closure reaction was carried out for 4 hours at ll °C. After the dehydration ring closure reaction, 'solvent substitution of the solvent in the system with a new N-methyl-2-pyrrolidone' yielded a ruthenium-imided polymer containing 20% by weight of a ruthenium iodide ratio of about 49% (B- 1) solution. A small amount of this solution was taken and diluted with N-methyl-2-pyrrolidone to a solution having a polymer concentration of 6.0% by weight, and the solution viscosity was determined to be 19 mPai. Example 1 4 (Preparation and evaluation of liquid crystal alignment agent) <Preparation of liquid crystal alignment agent> (1) Preparation of liquid crystal alignment agent for evaluation of printability The ruthenium-containing imidized polymer obtained in the above Example 6 (PI - 1) solution was added with N-methyl-2-pyrrolidone (NMP) and butyl cellosolve (BC) to form a solvent composition of NMP: BC = 50: 50 (weight ratio), solid content concentration of 6.0 % by weight solution. This solution was filtered through a filter having a pore size of 1 μm to prepare a liquid crystal alignment agent for evaluation of printability. (2) Preparation of liquid crystal alignment agent for producing liquid crystal display element To the solution of the ruthenium imidized polymer (ΡΙ-1) obtained in the above Example 6, Ν-methyl-2-pyrrolidone was added. (ΝΜΡ) and butyl cellosolve (BC), a solvent having a composition of NMP: BC = 50:50 (weight ratio) and a solid content concentration of 4% by weight. This solution was filtered through a filter having a pore size of μηη to prepare a liquid crystal alignment agent for producing a liquid crystal display element. <Evaluation of Liquid Crystal Aligning Agent> Using any of these liquid crystal alignment agents, evaluation was carried out by the following method. The evaluation results are shown in Table 1. -60-201001029 (1) Evaluation of the printability The liquid crystal alignment agent for the printability evaluation prepared above was applied by a liquid crystal alignment film printer (manufactured by Nippon Photo Printing Co., Ltd.) under the following conditions. The transparent electrode surface of the glass substrate of the transparent electrode was heated at 80 ° C for 1 minute (prebaking) to remove the solvent, and then heated at 2 Torr (TC for 60 minutes (post-baking) to form a coating having a film thickness of 60 nm. The film was visually observed to investigate the presence or absence of wrinkles and uneven coating. When uneven printing and pinholes were not observed, the printability was evaluated as "good". (2) Evaluation of vertical alignment control force was used. The liquid crystal alignment agent for producing a liquid crystal display element prepared above was applied onto an IT 0 film transparent conductive film provided on one surface of a glass substrate having a thickness of 1 mm by a spin coater, and heated at 80 ° C for 1 minute (prebaking) After removing the solvent, it was further heated at 200 ° C for 60 minutes to form a coating film having a film thickness of 0.08 μm. Then, using a sander equipped with a roller wound with a rayon cloth, the table was moved at a roller rotation speed of 400 rpm. speed The coating film was sanded at a thickness of 0.4 mm for 3 cm/sec, and then ultrasonically washed in ultrapure water for 10 minutes, followed by drying in a clean oven at 100 °C. In a minute, a substrate having a liquid crystal alignment film subjected to a rubbing treatment was produced, and this operation was repeated to produce a pair of (two pieces) substrates having a liquid crystal alignment film subjected to a rubbing treatment. Then, the pair of substrates had liquid crystals. On each outer edge of the alignment film, an epoxy resin adhesive having an alumina ball of 5.5 μm in diameter is applied, and then the liquid crystal alignment film surface is repeatedly pressed and pressed in parallel, and the adhesive is cured. Then, The liquid crystal injection port is filled with a nematic liquid-61 - 201001029 crystal (MLC-660 8 manufactured by MERCK) between the pair of substrates, and the liquid crystal injection port is sealed with an acrylic photocurable adhesive to produce vertical alignment control force. The liquid crystal cell for evaluation. When the pretilt angle measured by the crystal rotation angle method is 86° or more, the vertical alignment control force is evaluated as “good”, and when it is less than 86°, vertical In addition, it is known that the polishing process performed as described above has a reduction effect on the vertical alignment control force of the liquid crystal alignment film. Therefore, even if the polishing process is performed, the pretilt angle of 8 6° or more is displayed, and the vertical direction is vertical. The alignment control force can be said to be extremely excellent, and the liquid crystal alignment agent capable of obtaining such a result can be known from the experience, even when it is used for manufacturing a VA type liquid crystal display element by the ODF method. (3) Voltage The evaluation of the retention ratio was carried out in the same manner as in the above (2) evaluation of the vertical alignment control force except that the polishing treatment was not performed. At 60 ° C, 5 V was applied to the liquid crystal cell in a time span of 16.7 msec. The voltage and voltage application time was 60 microseconds, and then the voltage holding ratio from the voltage release to 16.7 milliseconds was measured. (4) Evaluation of heat resistance (alternative evaluation of long-term continuous drive resistance) For the liquid crystal cell manufactured in the same manner as described above, first, a voltage of 5 V was applied for a time span of 167 msec, and the voltage application time was 60 μm. Seconds, then the voltage holding ratio from the voltage release to 167 milliseconds is measured. The number at this time is taken as the initial voltage holding ratio (VHRBF). After the VHRBF was measured, the liquid crystal display element was placed in an oven at 100 ° C, and -60 - 201001029 was applied for 1 hour of thermal stress. Then, after the liquid crystal display element was cooled to room temperature in the chamber, the voltage holding ratio (VHRaf) after the application of the thermal stress was measured under the measurement conditions of the initial voltage holding ratio. The voltage change rate (Δ VHR) before and after the application of the thermal stress is obtained by the following formula (2), and Δ VHR (%) = ((VHRbf - VHRaf) - VHRbf) x 1 00. The rate of change is less than 5%. The heat resistance was evaluated as "good 5% or more, and heat resistance was evaluated as "poor". The evaluation results are shown in Table 1. Example 1 5 to 2 3. Comparative Example 1 The composition of the liquid crystal alignment agent was as shown in Table 1, respectively. In the same manner as in Example 1 4 described above, two types of liquid crystal alignment agents were prepared in the same manner, and in Examples 15 and 1 7 to 23, after a predetermined solvent was dissolved in the polymer, the polymer was further added to 100 parts by weight of the polymer. 20 parts by weight of the epoxy compound represented by the following formula (E-1). The same holding ratio of the temperature (2) ” is added to the evaluation liquid.

各自的結果列於表1。 -63- 201001029 表1 液晶配向劑 液晶胞 聚合物 種類 環氧基化 合物種類 印刷性 垂直配向控制力 電壓保持率 (%) 耐熱性 實施例14 PI—1 — 良好 良好 99 良好 實施例15 PI—1 E-1 良好 良好 99 良好 實施例16 PI-2 — 良好 良好 99 良好 實施例17 PI-2 E-1 良好 良好 99 良好 實施例18 PI-3 E-1 良好 良好 99 良好 實施例19 PI—4 E-1 良好 良好 99 良好 實施例20 PI—5 E-1 良好 良好 99 良好 實施例21 PI-6 E—1 良好 良好 99 良好 實施例22 PI—7 E-1 良好 良好 99 良好 實施例23 PI—8 E-1 良好 良好 99 良好 比較例1 B-1 — 良好 不良 98 不良 【圖式簡單說明】 〇 j\w 【主要元件符號說明】 te 。 -64-The respective results are listed in Table 1. -63-201001029 Table 1 Liquid crystal alignment agent Liquid crystal cell polymer type Epoxy compound type Printability Vertical alignment control force Voltage retention ratio (%) Heat resistance Example 14 PI-1 - Good good 99 Good example 15 PI-1 E-1 Good and good 99 Good example 16 PI-2 - Good good 99 Good example 17 PI-2 E-1 Good good 99 Good example 18 PI-3 E-1 Good good 99 Good example 19 PI-4 E-1 Good and good 99 Good example 20 PI-5 E-1 Good good 99 Good example 21 PI-6 E-1 Good good 99 Good example 22 PI-7 E-1 Good good 99 Good example 23 PI —8 E-1 Good and good 99 Good comparative example 1 B-1 — Good bad 98 Bad [Simplified illustration] 〇j\w [Description of main component symbols] te . -64-

Claims (1)

201001029 七、申請專利範圍: 1. 一種液晶配向劑,其特徵在於包括選自聚酸胺酸及其醯 亞胺化聚合物構成的群組中的至少一種聚合物’該聚酿 胺酸使四羧酸二野與含有下述式(A)表示的化合物的一 胺反應所製得,201001029 VII. Patent application scope: 1. A liquid crystal alignment agent characterized by comprising at least one polymer selected from the group consisting of polyamic acid and its ruthenium iodide polymer. The carboxylic acid di野 is prepared by reacting a monoamine containing a compound represented by the following formula (A), (A) (式(A)中,R1和R111各自獨立地爲醚鍵、硫醚鍵、醋鍵 或硫酯鍵,其中酯鍵和硫酯鍵的方向不限,R11爲亞 或碳原子數爲2〜10的亞烷基,RIV爲單鍵、亞甲基或亞 乙基,X爲具有甾體骨架的碳原子數爲17〜40的1價有' 機基團)。 2.如申請專利範圍第丨項的液晶配向劑,其中上述式(Α)Φ 的X基團爲下述式(X — 1— 1)或(Χ—2—1)表示的基團’ -65- 201001029(A) (In the formula (A), R1 and R111 are each independently an ether bond, a thioether bond, a vinegar bond or a thioester bond, wherein the direction of the ester bond and the thioester bond is not limited, and R11 is a sub or a carbon number. The alkylene group is 2 to 10, and the RIV is a single bond, a methylene group or an ethylene group, and X is a monovalent organic group having a steroid skeleton having a carbon number of 17 to 40. 2. The liquid crystal alignment agent of the invention of claim 3, wherein the X group of the above formula (Α)Φ is a group represented by the following formula (X-1 - 1) or (Χ-2 - 1) - 65- 201001029 上述式中的表示連接鍵。 3 . —種液晶顯示元件,其特徵在於具有由如申請 第1或2項的液晶配向劑形成的液晶配向膜。 4. 一種聚醯胺酸或其醯亞胺化聚合物,其係由四 與含有上述式(A)表示的化合物的二胺反應製得 5. —種化合物,係由上述式(A)表示。 專利範圍 羧酸二酐 -66 - 201001029 四、指定代表圖: (一) 本案指定代表圖為:無。 (二) 本代表圖之元件符號簡單說明: te 〇 j\w 五、本案若有化學式時,請揭示最能顯示發明特徵的化學式:The connection key is represented by the above formula. A liquid crystal display element characterized by having a liquid crystal alignment film formed of the liquid crystal alignment agent of claim 1 or 2. A polyaminic acid or a quinone imidized polymer thereof, which is obtained by reacting four diamines containing a compound represented by the above formula (A) to obtain a compound of the formula (A). . Patent scope: carboxylic acid dianhydride -66 - 201001029 IV. Designation of representative drawings: (1) The representative representative of the case is: None. (2) A brief description of the symbol of the representative figure: te 〇 j\w 5. If there is a chemical formula in this case, please disclose the chemical formula that best shows the characteristics of the invention: nh2 (A)Nh2 (A)
TW098107226A 2008-03-07 2009-03-06 Liquid crystal aligning agent and liquid crystal aligning element TWI454805B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2008058033 2008-03-07

Publications (2)

Publication Number Publication Date
TW201001029A true TW201001029A (en) 2010-01-01
TWI454805B TWI454805B (en) 2014-10-01

Family

ID=41094629

Family Applications (1)

Application Number Title Priority Date Filing Date
TW098107226A TWI454805B (en) 2008-03-07 2009-03-06 Liquid crystal aligning agent and liquid crystal aligning element

Country Status (4)

Country Link
JP (1) JP5360376B2 (en)
KR (1) KR101520494B1 (en)
CN (1) CN101526700B (en)
TW (1) TWI454805B (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9505981B2 (en) 2014-03-25 2016-11-29 Chi Mei Corporation Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display device
US10100255B2 (en) 2014-12-11 2018-10-16 Chi Mei Corporation Liquid crystal alignment agent and liquid crystal alignment film and liquid crystal display element formed from the liquid crystal alignment agent
US10100254B2 (en) 2014-12-11 2018-10-16 Chi Mei Corporation Liquid crystal alignment agent and liquid crystal alignment film and liquid crystal display element formed from the liquid crystal alignment agent

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5408415B2 (en) * 2009-06-10 2014-02-05 Jsr株式会社 Method for producing 1-substituted 3,5-diaminobenzene
JP5657902B2 (en) * 2010-03-17 2015-01-21 株式会社コスモステクニカルセンター Polyoxyalkylene sterol ether derivative and / or polyoxyalkylene stanol ether derivative, and external preparation composition containing the same
JP6127982B2 (en) * 2012-01-12 2017-05-17 和光純薬工業株式会社 Liquid crystal alignment agent
TWI482801B (en) 2013-09-18 2015-05-01 Chi Mei Corp Liquid crystal alignment composition, liquid crystal alignment film and liquid crystal display element having thereof
TWI527844B (en) * 2014-06-06 2016-04-01 奇美實業股份有限公司 Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display device
TWI534203B (en) 2014-07-24 2016-05-21 奇美實業股份有限公司 Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display device

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2893671B2 (en) * 1991-03-11 1999-05-24 ジェイエスアール株式会社 Liquid crystal alignment agent
JP4168442B2 (en) * 2002-07-29 2008-10-22 Jsr株式会社 Diamine compound, polyamic acid, imidized polymer, liquid crystal aligning agent, and liquid crystal display element
JP4569145B2 (en) * 2004-03-25 2010-10-27 チッソ株式会社 Polyimide copolymer, liquid crystal aligning agent and liquid crystal display element using the same
JP4840137B2 (en) * 2004-04-28 2011-12-21 日産化学工業株式会社 Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element using the same
CN101633621A (en) * 2004-04-28 2010-01-27 日产化学工业株式会社 Liquid crystal orientation agent, liquid crystal orientation film and liquid crystal display element using liquid crystal orientation agent
JP4502119B2 (en) * 2004-06-24 2010-07-14 Jsr株式会社 Vertical liquid crystal display device having a reflective electrode
TWI352073B (en) * 2004-10-05 2011-11-11 Jsr Corp New diamine,polymer and liquid crystal alignment a
JP4900560B2 (en) * 2004-10-05 2012-03-21 Jsr株式会社 Novel diamine compound, polymer and liquid crystal aligning agent
TWI386434B (en) * 2005-01-19 2013-02-21 Jsr Corp Liquid crystal orientation agent and liquid crystal display element
JP4788890B2 (en) * 2005-01-19 2011-10-05 Jsr株式会社 Liquid crystal aligning agent and liquid crystal display element
JP4605376B2 (en) * 2005-06-06 2011-01-05 Jsr株式会社 Liquid crystal aligning agent and liquid crystal display element
JP4984023B2 (en) * 2006-01-20 2012-07-25 Jsr株式会社 Novel diamine compound and process for producing the same
JP5035523B2 (en) * 2006-04-25 2012-09-26 Jsr株式会社 Vertical alignment type liquid crystal aligning agent and vertical alignment type liquid crystal display element
JP2008013501A (en) * 2006-07-06 2008-01-24 Jsr Corp Novel diamine compound and method for preparing the same

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9505981B2 (en) 2014-03-25 2016-11-29 Chi Mei Corporation Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display device
TWI585157B (en) * 2014-03-25 2017-06-01 奇美實業股份有限公司 Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display device having the same
US10100255B2 (en) 2014-12-11 2018-10-16 Chi Mei Corporation Liquid crystal alignment agent and liquid crystal alignment film and liquid crystal display element formed from the liquid crystal alignment agent
US10100254B2 (en) 2014-12-11 2018-10-16 Chi Mei Corporation Liquid crystal alignment agent and liquid crystal alignment film and liquid crystal display element formed from the liquid crystal alignment agent

Also Published As

Publication number Publication date
JP5360376B2 (en) 2013-12-04
TWI454805B (en) 2014-10-01
KR101520494B1 (en) 2015-05-14
JP2009237545A (en) 2009-10-15
CN101526700B (en) 2012-11-07
KR20090096355A (en) 2009-09-10
CN101526700A (en) 2009-09-09

Similar Documents

Publication Publication Date Title
TWI518112B (en) Liquid crystal alignment agent, liquid crystal alignment film and a liquid crystal display element, and compounds and polymers used in manufacture of those
TWI468435B (en) Liquid crystal aligning agent, liquid crystal display element and compound
TWI434111B (en) Liquid crystal aligning agent and liquid crystal display element
TWI499641B (en) Liquid crystal alignment agent, liquid crystal display element, polyamic acid, polyimide and compound
TWI448486B (en) Liquid crystal alignment agent, liquid crystal alignment film, liquid crystal display element, polylysine, ruthenium iodide polymer and compound
TWI482799B (en) A liquid crystal alignment agent, a liquid crystal alignment film, a method for forming the same, and a liquid crystal display device
TWI432484B (en) Liquid crystal alignment agent and liquid crystal display element
TWI356068B (en) Liquid crystal alignment agent and liquid crystal
TWI454805B (en) Liquid crystal aligning agent and liquid crystal aligning element
TWI433870B (en) Liquid crystal aligning agent and liquid crystal display element
TWI591125B (en) Liquid crystal alignment agent, liquid crystal alignment film, liquid crystal display device, polymer, and compound
TW201006869A (en) Liquid crystal alignment agent and liquid crystal display element
TWI468813B (en) Liquid crystal aligning agent and liquid crystal display element
TWI454806B (en) Liquid crystal alignment agent, liquid crystal display element, polyamic acid, imidized polymer and compound
TW200832019A (en) Liguid crystal alignment agent and liquid crystal display element
TWI501011B (en) Liquid crystal aligning agent and liquid crystal display element
TW201005004A (en) Liquid crystal aligning agent, liquid crystal aligning film and liquid crystal display element
TWI444727B (en) Liquid crystal alignment agent and liquid crystal display element
TWI427103B (en) Liquid crystal aligning agent and liquid crystal display element
TWI467290B (en) Liquid crystal aligning agent, liquid crystal display element, polyamic acid, polyimide and compound
TWI429685B (en) Liquid crystal aligning agent and liquid crystal display element
TWI428370B (en) Liquid crystal aligning agent and liquid crystal display element
TWI468438B (en) Liquid crystal alignment agent
TWI461460B (en) Liquid aligning agent liquid crystal aligning film and liquid crystal display element
TW200819510A (en) Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element